HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 50704,
"recordsTotal": 50704,
"next": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&start=48000",
"previous": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&start=47400",
"results": [
{
"registry_id": "NCT07340658",
"publication_url": "https://clinicaltrials.gov/study/NCT07340658",
"title": "A Multicenter, Randomized, Double-Blind, Double-Dummy, Phase III Study to Evaluate the Efficacy and Safety of Letrozole SIE Compared to Femara® (Both in Combination With the CDK4/6 Inhibitor Ribociclib) in Postmenopausal Women With HR-Positive, HER2-Negative, Inoperable Locally Advanced or Metastatic Breast Cancer (SIE-3)",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Rovi Pharmaceuticals Laboratories",
"sponsor_slug": "rovi-pharmaceuticals-laboratories",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07596485",
"publication_url": "https://clinicaltrials.gov/study/NCT07596485",
"title": "A Phase 1/2, Multicenter, Open-Label Study to Evaluate Safety, Tolerability, and PRELIminary EFficacy of Percutaneous Injection of RP-008 Followed by Daily Oral Varenicline in Patients With Trigeminal Neuralgia (The RELIEF Study)",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Kriya Therapeutics, Inc.",
"sponsor_slug": "kriya-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07723534",
"publication_url": "https://clinicaltrials.gov/study/NCT07723534",
"title": "A Single Arm Phase II Trial of Zolbetuximab in Combination With mFOLFOX6 or CAPOX Chemotherapy in Claudin 18.2 Overexpressed Advanced or Metastatic Biliary Tract Cancers",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Midhun Malla",
"sponsor_slug": "midhun-malla",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07609719",
"publication_url": "https://clinicaltrials.gov/study/NCT07609719",
"title": "A Prospective, Multicenter, Single-arm Study of Ocrelizumab Administered Subcutaneously in Patients With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy",
"has_exemption": false,
"start_date": "2026-09-02",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Genentech, Inc.",
"sponsor_slug": "genentech-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07325201",
"publication_url": "https://clinicaltrials.gov/study/NCT07325201",
"title": "Mitigating Diabetic Ketoacidosis in People With T1D and Chronic Kidney Disease on an SGLT1&2 Inhibitor: Ketosis Risk Factor Determination and Incorporation Into an Enhanced Glucose Ketone Report",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "HealthPartners Institute",
"sponsor_slug": "healthpartners-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07778667",
"publication_url": "https://clinicaltrials.gov/study/NCT07778667",
"title": "A Multicenter, Open-label, Single-arm, Baseline-controlled Trial to Assess the Efficacy and Safety of Lucerastat in Treatment-naïve/Pseudo-naïve Adult Male Participants With Fabry Disease",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Idorsia Pharmaceuticals Ltd.",
"sponsor_slug": "idorsia-pharmaceuticals-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07205601",
"publication_url": "https://clinicaltrials.gov/study/NCT07205601",
"title": "Phase 2a Assessment of Safety, Tolerability, and Efficacy of Repeated Dosing of Intracerebroventricular Injections of Ex Vivo Expanded, Autologous Adipose-Derived Stem Cells (RB-ADSCs) in Participants With Mild to Moderate Alzheimer's Disease",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneration Biomedical, Inc.",
"sponsor_slug": "regeneration-biomedical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07783191",
"publication_url": "https://clinicaltrials.gov/study/NCT07783191",
"title": "Rapid Rehydration in the Treatment of Severe Hypernatremia",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Columbia University",
"sponsor_slug": "columbia-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07643519",
"publication_url": "https://clinicaltrials.gov/study/NCT07643519",
"title": "Neoadjuvant Enfortumab Vedotin Plus Pembrolizumab in Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Carcinoma",
"has_exemption": false,
"start_date": "2026-12-31",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06783504",
"publication_url": "https://clinicaltrials.gov/study/NCT06783504",
"title": "Effect Of Percutaneous Electrical Nerve Field Stimulation (PENFS) On Symptom Control And Autonomic Nervous System Activity In Patients With Diabetes Mellitus",
"has_exemption": false,
"start_date": "2027-02-10",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Indiana University",
"sponsor_slug": "indiana-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06251609",
"publication_url": "https://clinicaltrials.gov/study/NCT06251609",
"title": "Naloxone for Opioid Associated Out of Hospital Cardiac Arrest",
"has_exemption": false,
"start_date": "2027-03-31",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06907485",
"publication_url": "https://clinicaltrials.gov/study/NCT06907485",
"title": "A Multicenter Study to Assess the Feasibility of Gleolan (ALA / Aminolevulinic Acid HCl) in Pediatric Brain Tumor Patients After Delayed Administration",
"has_exemption": false,
"start_date": "2027-08-31",
"completion_date": "2029-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Costas Hadjipanayis",
"sponsor_slug": "costas-hadjipanayis",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03949855",
"publication_url": "https://clinicaltrials.gov/study/NCT03949855",
"title": "Belimumab and Rituximab Compared to Rituximab Alone for the Treatment of Primary Membranous Nephropathy (ITN080AI)",
"has_exemption": false,
"start_date": "2020-03-06",
"completion_date": "2029-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05390892",
"publication_url": "https://clinicaltrials.gov/study/NCT05390892",
"title": "PRECIDENTD: PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes",
"has_exemption": false,
"start_date": "2022-09-26",
"completion_date": "2029-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05432466",
"publication_url": "https://clinicaltrials.gov/study/NCT05432466",
"title": "A Phase 3 Randomized, Double-Blind, Decentralized Clinical Trial to Compare the Efficacy of Celiprolol to Placebo in the Treatment of Patients With COL3A1-Positive Vascular Ehlers-Danlos Syndrome",
"has_exemption": false,
"start_date": "2022-11-07",
"completion_date": "2029-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Acer Therapeutics Inc.",
"sponsor_slug": "acer-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06072768",
"publication_url": "https://clinicaltrials.gov/study/NCT06072768",
"title": "Using SMART Design to Develop Dynamic Treatment Regimens for Glucocorticoid Tapering",
"has_exemption": false,
"start_date": "2023-03-09",
"completion_date": "2029-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06014255",
"publication_url": "https://clinicaltrials.gov/study/NCT06014255",
"title": "A Phase 2 Randomized Trial of Neoadjuvant Enoblituzumab Versus Standard of Care in Men With High-Risk Localized Prostate Cancer: The Help Elucidate & Attack Longitudinally (HEAT) Prostate Cancer Randomized Study",
"has_exemption": false,
"start_date": "2024-02-16",
"completion_date": "2029-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05896228",
"publication_url": "https://clinicaltrials.gov/study/NCT05896228",
"title": "Phase 2, Single-Arm Study of Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2024-02-20",
"completion_date": "2029-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Benjamin T Diamond, MD",
"sponsor_slug": "benjamin-t-diamond-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05937854",
"publication_url": "https://clinicaltrials.gov/study/NCT05937854",
"title": "Effect of PDE5 Inhibitor on Respiratory Symptoms in COPD Complicated by Pulmonary Hypertension",
"has_exemption": false,
"start_date": "2024-04-01",
"completion_date": "2029-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06412198",
"publication_url": "https://clinicaltrials.gov/study/NCT06412198",
"title": "A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations",
"has_exemption": false,
"start_date": "2024-08-28",
"completion_date": "2029-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06400121",
"publication_url": "https://clinicaltrials.gov/study/NCT06400121",
"title": "Phase 2, Randomized, Double-Blind, Placebo-Controlled, Single Intravenous Dose, Parallel Efficacy Study of Apimostinel With or Without Subsequent Automated Self-Association Training in Subjects With Major Depressive Disorder",
"has_exemption": false,
"start_date": "2024-10-28",
"completion_date": "2029-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Rebecca Price",
"sponsor_slug": "rebecca-price",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06972056",
"publication_url": "https://clinicaltrials.gov/study/NCT06972056",
"title": "A Comparative Effectiveness Study of Oral Medications Used for Migraine Prevention: The APT Comparison Study",
"has_exemption": false,
"start_date": "2025-07-09",
"completion_date": "2029-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07038824",
"publication_url": "https://clinicaltrials.gov/study/NCT07038824",
"title": "A 2-Part, Randomized, Double-Blind, Placebo-Controlled Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping With an Initial Multiple Ascending Dose Part A to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ENTR-601-45, Followed by Part B to Evaluate the Safety and Efficacy of ENTR-601-45 (ELEVATE-45)",
"has_exemption": false,
"start_date": "2025-08-30",
"completion_date": "2029-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Entrada Therapeutics, Inc.",
"sponsor_slug": "entrada-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07135895",
"publication_url": "https://clinicaltrials.gov/study/NCT07135895",
"title": "The Artix All-in-one Solution for Complete thrombEctomy With eNDovascular Approach",
"has_exemption": false,
"start_date": "2026-01-07",
"completion_date": "2029-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Inari Medical",
"sponsor_slug": "inari-medical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07187011",
"publication_url": "https://clinicaltrials.gov/study/NCT07187011",
"title": "Phase 2a Trial: Efficacy and Safety of PT150 in the Treatment of US Veterans With Posttraumatic Stress Disorder (PTSD)",
"has_exemption": false,
"start_date": "2026-04-01",
"completion_date": "2029-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "San Diego Veterans Healthcare System",
"sponsor_slug": "san-diego-veterans-healthcare-system",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06941415",
"publication_url": "https://clinicaltrials.gov/study/NCT06941415",
"title": "Bumetanide vs. Furosemide for Adults Hospitalized With Cirrhosis: the BUFF Trial",
"has_exemption": false,
"start_date": "2026-06-03",
"completion_date": "2029-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Stacy Johnson",
"sponsor_slug": "stacy-johnson",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06513949",
"publication_url": "https://clinicaltrials.gov/study/NCT06513949",
"title": "Phase 2, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Anti-CD14 Treatment With a Recombinant Chimeric Monoclonal Antibody (IC14) in Hospitalized Patients With Acute Respiratory Distress Syndrome",
"has_exemption": false,
"start_date": "2026-06-17",
"completion_date": "2029-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Implicit Bioscience",
"sponsor_slug": "implicit-bioscience",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07016321",
"publication_url": "https://clinicaltrials.gov/study/NCT07016321",
"title": "Emetine for Viral Outbreaks: A Phase 2/3 Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Emetine for Dengue Fever (a.k.a. EVOLVE Antiviral Initiative)",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2029-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07670650",
"publication_url": "https://clinicaltrials.gov/study/NCT07670650",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of SAB-142 for Delaying the Progression of Type 1 Diabetes (T1D) in Patients With Stage 3 New Onset T1D, Recent Onset T1D, and Established T1D",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2029-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07686731",
"publication_url": "https://clinicaltrials.gov/study/NCT07686731",
"title": "Suvorexant: Targeting Orexin to Augment Exposure Therapy in Veterans With PTSD and Insomnia",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2029-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Northern California Institute of Research and Education",
"sponsor_slug": "northern-california-institute-of-research-and-education",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07226713",
"publication_url": "https://clinicaltrials.gov/study/NCT07226713",
"title": "A Single-Arm, Open-label, Phase II Study Evaluating Pacritinib in Participants With Metastatic Castrate-Resistant Prostate Cancer That Progressed on or After Prior Treatment With Androgen Receptor Signaling Inhibitors - (POSTPONE)",
"has_exemption": false,
"start_date": "2026-09-03",
"completion_date": "2029-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07806149",
"publication_url": "https://clinicaltrials.gov/study/NCT07806149",
"title": "NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Multi-Center Prospective Study Using Improvised Off-Label Devices",
"has_exemption": false,
"start_date": "2026-10-25",
"completion_date": "2029-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Heart, Lung, and Blood Institute (NHLBI)",
"sponsor_slug": "national-heart-lung-and-blood-institute-nhlbi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06708455",
"publication_url": "https://clinicaltrials.gov/study/NCT06708455",
"title": "Phase 2 Trial of Autologous Rapamycin-Resistant Th1/Tc1 (RAPA-201) Cell Therapy of PD-(L)1 Resistant Malignant Melanoma",
"has_exemption": false,
"start_date": "2027-03-01",
"completion_date": "2029-03-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Rapa Therapeutics LLC",
"sponsor_slug": "rapa-therapeutics-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07596901",
"publication_url": "https://clinicaltrials.gov/study/NCT07596901",
"title": "A Double-Blind, Randomized, Placebo-Controlled Study to Investigate the Safety and Efficacy of Aritinercept, a Dual BAFF/APRIL Inhibitor, in Patients With Generalized Myasthenia Gravis",
"has_exemption": false,
"start_date": "2026-04-22",
"completion_date": "2029-03-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Aurinia Pharmaceuticals Inc.",
"sponsor_slug": "aurinia-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07611214",
"publication_url": "https://clinicaltrials.gov/study/NCT07611214",
"title": "PRESERVE: A Multi-Center Phase 4 Study of the Efficacy and Safety of LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab at Inducing Rapid Renal Response in Patients With Lupus Nephritis",
"has_exemption": false,
"start_date": "2026-04-22",
"completion_date": "2029-03-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Aurinia Pharmaceuticals Inc.",
"sponsor_slug": "aurinia-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07501702",
"publication_url": "https://clinicaltrials.gov/study/NCT07501702",
"title": "A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With a Long-term Extension of Povetacicept in Adults With Generalized Myasthenia Gravis",
"has_exemption": false,
"start_date": "2026-05-13",
"completion_date": "2029-03-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Vertex Pharmaceuticals Incorporated",
"sponsor_slug": "vertex-pharmaceuticals-incorporated",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07652294",
"publication_url": "https://clinicaltrials.gov/study/NCT07652294",
"title": "A Study to Evaluate the Long-term Safety and Efficacy of Long-acting Antibodies as Single Agents and in Combinations in Participants With Inflammatory Bowel Disease",
"has_exemption": false,
"start_date": "2026-06-08",
"completion_date": "2029-03-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Spyre Therapeutics, Inc.",
"sponsor_slug": "spyre-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07686263",
"publication_url": "https://clinicaltrials.gov/study/NCT07686263",
"title": "A Phase 3 Double-blind, Placebo-controlled Randomized Withdrawal Maintenance Trial of KarXT Treatment in Participants With Schizophrenia",
"has_exemption": false,
"start_date": "2026-08-20",
"completion_date": "2029-03-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Karuna Therapeutics, Inc., a Bristol Myers Squibb company",
"sponsor_slug": "karuna-therapeutics-inc-a-bristol-myers-squibb-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07854782",
"publication_url": "https://clinicaltrials.gov/study/NCT07854782",
"title": "A Phase 3, Randomized, Double-blind, Placebo-controlled Trial of ALN-CIDEB in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)",
"has_exemption": false,
"start_date": "2026-11-06",
"completion_date": "2029-03-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07042919",
"publication_url": "https://clinicaltrials.gov/study/NCT07042919",
"title": "A Phase Ib/II Study of Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Hepatocellular Carcinoma",
"has_exemption": false,
"start_date": "2026-03-30",
"completion_date": "2029-03-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Devalingam Mahalingam",
"sponsor_slug": "devalingam-mahalingam",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06112418",
"publication_url": "https://clinicaltrials.gov/study/NCT06112418",
"title": "A Randomized Comparison of Cleerly Coronary Artery Disease Stage-Based Care Versus Risk Factor-Based Care for Primary Prevention of Cardiovascular Events",
"has_exemption": false,
"start_date": "2024-03-06",
"completion_date": "2029-03-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Cleerly, Inc.",
"sponsor_slug": "cleerly-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07782957",
"publication_url": "https://clinicaltrials.gov/study/NCT07782957",
"title": "A Randomized, Double-blind, Parallel Group Phase 3 Study to Assess the Efficacy and Safety of GSK5784283 (Felcorekibart) in Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) (PERSIST CRSwNP-2)",
"has_exemption": false,
"start_date": "2026-09-03",
"completion_date": "2029-03-06",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07782970",
"publication_url": "https://clinicaltrials.gov/study/NCT07782970",
"title": "A Randomized, Double-blind, Parallel Group Phase 3 Study to Assess the Efficacy and Safety of GSK5784283 (Felcorekibart) in Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) (PERSIST CRSwNP-1)",
"has_exemption": false,
"start_date": "2026-09-28",
"completion_date": "2029-03-06",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07227298",
"publication_url": "https://clinicaltrials.gov/study/NCT07227298",
"title": "AN INTERVENTIONAL OPEN-LABEL PHASE 1B/2 STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS, AND PRELIMINARY EFFICACY OF PF-08634404 IN COMBINATION WITH DIFFERENT ANTICANCER AGENTS IN PARTICIPANTS WITH ADVANCED SOLID TUMORS",
"has_exemption": false,
"start_date": "2026-01-30",
"completion_date": "2029-03-08",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06665256",
"publication_url": "https://clinicaltrials.gov/study/NCT06665256",
"title": "A Phase 2, Randomized, Open-label, Controlled Study to Evaluate the Efficacy and Safety of Rapcabtagene Autoleucel Versus Comparator in Participants With Severe Refractory Idiopathic Inflammatory Myopathies (IIM)",
"has_exemption": false,
"start_date": "2024-12-17",
"completion_date": "2029-03-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07769372",
"publication_url": "https://clinicaltrials.gov/study/NCT07769372",
"title": "A Pilot Study of Focal Magnetic Resonance (MR)-Guided Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer",
"has_exemption": false,
"start_date": "2027-01-01",
"completion_date": "2029-03-09",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05174169",
"publication_url": "https://clinicaltrials.gov/study/NCT05174169",
"title": "Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease",
"has_exemption": false,
"start_date": "2022-07-08",
"completion_date": "2029-03-10",
"has_results": false,
"results_due": false,
"sponsor_name": "NRG Oncology",
"sponsor_slug": "nrg-oncology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06883305",
"publication_url": "https://clinicaltrials.gov/study/NCT06883305",
"title": "A Randomised, Double-blind, Placebo-controlled, Parallel Group, Multicentre, Phase III Study to Evaluate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease",
"has_exemption": false,
"start_date": "2025-03-18",
"completion_date": "2029-03-13",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06878261",
"publication_url": "https://clinicaltrials.gov/study/NCT06878261",
"title": "A Randomised, Double-blind, Placebo-controlled, Parallel Group, Multicentre, Phase III Study to Evaluate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease",
"has_exemption": false,
"start_date": "2025-03-25",
"completion_date": "2029-03-13",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06134362",
"publication_url": "https://clinicaltrials.gov/study/NCT06134362",
"title": "A Phase IIIB, Long-Term Follow-Up of CAB LA for Participants in HPTN 083 and HPTN 084 CAB PrEP Studies at Risk of HIV Acquisition",
"has_exemption": false,
"start_date": "2024-05-14",
"completion_date": "2029-03-14",
"has_results": false,
"results_due": false,
"sponsor_name": "ViiV Healthcare",
"sponsor_slug": "viiv-healthcare",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06637423",
"publication_url": "https://clinicaltrials.gov/study/NCT06637423",
"title": "A Phase 1/2 Open-label Clinical Study to Evaluate the Safety and Efficacy of Intravesical Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in Participants With Intermediate-risk Non-muscle Invasive Bladder Cancer (NMIBC)",
"has_exemption": false,
"start_date": "2024-12-20",
"completion_date": "2029-03-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07794761",
"publication_url": "https://clinicaltrials.gov/study/NCT07794761",
"title": "A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF ONCE-WEEKLY BEROBENATIDE IN ADULTS WITH OBESITY DISEASE IN JAPAN (VESPER-JW)",
"has_exemption": false,
"start_date": "2026-10-02",
"completion_date": "2029-03-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05827016",
"publication_url": "https://clinicaltrials.gov/study/NCT05827016",
"title": "A Phase 3, Two-stage, Randomized, Multi-center, Controlled, Open-label Study Comparing Iberdomide Maintenance to Lenalidomide Maintenance Therapy After Autologous Stem Cell Transplantation (ASCT) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) (EXCALIBER-Maintenance)",
"has_exemption": false,
"start_date": "2023-06-22",
"completion_date": "2029-03-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04305691",
"publication_url": "https://clinicaltrials.gov/study/NCT04305691",
"title": "A Phase 2 Trial of Ixazomib for Kaposi Sarcoma",
"has_exemption": false,
"start_date": "2023-11-07",
"completion_date": "2029-03-15",
"has_results": false,
"results_due": false,
"sponsor_name": "AIDS Malignancy Consortium",
"sponsor_slug": "aids-malignancy-consortium",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07225361",
"publication_url": "https://clinicaltrials.gov/study/NCT07225361",
"title": "Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis",
"has_exemption": false,
"start_date": "2025-11-28",
"completion_date": "2029-03-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07584707",
"publication_url": "https://clinicaltrials.gov/study/NCT07584707",
"title": "Investigation of Motorized Lower-limb Prostheses",
"has_exemption": false,
"start_date": "2026-04-16",
"completion_date": "2029-03-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Northern Arizona University",
"sponsor_slug": "northern-arizona-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07681713",
"publication_url": "https://clinicaltrials.gov/study/NCT07681713",
"title": "Evaluation of Long-Term Efficacy of Vatiquinone for the Treatment of Friedreich's Ataxia",
"has_exemption": false,
"start_date": "2026-08-15",
"completion_date": "2029-03-15",
"has_results": false,
"results_due": false,
"sponsor_name": "PTC Therapeutics",
"sponsor_slug": "ptc-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07520110",
"publication_url": "https://clinicaltrials.gov/study/NCT07520110",
"title": "Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis (MAVRIC)",
"has_exemption": false,
"start_date": "2026-09-28",
"completion_date": "2029-03-15",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Massachusetts, Worcester",
"sponsor_slug": "university-of-massachusetts-worcester",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07810738",
"publication_url": "https://clinicaltrials.gov/study/NCT07810738",
"title": "Biotype-assigned Augmentation Approach in Resistant Late-Life Depression (BAARD): a Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2029-03-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06005493",
"publication_url": "https://clinicaltrials.gov/study/NCT06005493",
"title": "A Phase I/II Open-label Dose Escalation and Dose Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of AZD5863, a T Cell-engaging Bispecific Antibody That Targets Claudin 18.2 (CLDN18.2) and CD3 in Adult Participants With Advanced or Metastatic Solid Tumors",
"has_exemption": false,
"start_date": "2023-07-11",
"completion_date": "2029-03-16",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07238400",
"publication_url": "https://clinicaltrials.gov/study/NCT07238400",
"title": "Cardiac Effects of Mineralocorticoid Receptor Antagonism After Hypertensive Disorders of Pregnancy",
"has_exemption": false,
"start_date": "2026-03-20",
"completion_date": "2029-03-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06495125",
"publication_url": "https://clinicaltrials.gov/study/NCT06495125",
"title": "A Phase 2 Study of Defactinib and Avutometinib, in Combination With Nivolumab for Patients With Anti-PD1 Refractory LKB1-Mutant Advanced Lung Adenocarcinoma",
"has_exemption": false,
"start_date": "2024-07-31",
"completion_date": "2029-03-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05855200",
"publication_url": "https://clinicaltrials.gov/study/NCT05855200",
"title": "A Phase 3, Open-Label, Randomized Study of Perioperative Dostarlimab Monotherapy Versus Standard of Care in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer",
"has_exemption": false,
"start_date": "2023-08-01",
"completion_date": "2029-03-19",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06787950",
"publication_url": "https://clinicaltrials.gov/study/NCT06787950",
"title": "A Phase I/IIa Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Anti-tumor Activity of ASN-3186 in Patients with Advanced Solid Tumors.",
"has_exemption": false,
"start_date": "2025-02-20",
"completion_date": "2029-03-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Jiangsu Yahong Meditech Co., Ltd aka Asieris",
"sponsor_slug": "jiangsu-yahong-meditech-co-ltd-aka-asieris",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07316010",
"publication_url": "https://clinicaltrials.gov/study/NCT07316010",
"title": "Phase 2 Trial of Lisocabtagene Maraleucel for Minimal Residual Disease in Patients With Large B-cell Lymphoma",
"has_exemption": false,
"start_date": "2026-03-17",
"completion_date": "2029-03-21",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04569747",
"publication_url": "https://clinicaltrials.gov/study/NCT04569747",
"title": "20-347 NCT Number Title A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer (ADEPT)",
"has_exemption": false,
"start_date": "2021-01-11",
"completion_date": "2029-03-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Dana-Farber Cancer Institute",
"sponsor_slug": "dana-farber-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07830732",
"publication_url": "https://clinicaltrials.gov/study/NCT07830732",
"title": "A Multinational, Open-label Study to Investigate Efficacy and Safety of Denecimig (Mim8) in Adults With Acquired Haemophilia A",
"has_exemption": false,
"start_date": "2026-10-09",
"completion_date": "2029-03-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06432036",
"publication_url": "https://clinicaltrials.gov/study/NCT06432036",
"title": "RENEGADE: Radioembolization for Early Stage Renal Cell Carcinoma: An Open-Label, Prospective, Multi-Center, Phase 1/2 Safety Trial",
"has_exemption": false,
"start_date": "2024-12-26",
"completion_date": "2029-03-24",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06669572",
"publication_url": "https://clinicaltrials.gov/study/NCT06669572",
"title": "A Phase II, Multi-center, Single Arm Trial of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Locally Advanced and/or Metastatic Anorectal Squamous Cell Carcinoma (ASCC) After Progression on First Line Chemotherapy.",
"has_exemption": false,
"start_date": "2025-07-11",
"completion_date": "2029-03-26",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07868328",
"publication_url": "https://clinicaltrials.gov/study/NCT07868328",
"title": "A Phase II, Randomized, Double Blind, Placebo-controlled, Basket Study to Evaluate the Safety, Tolerability and Pharmacodynamics of NIO752 in Participants With Primary Tauopathies",
"has_exemption": false,
"start_date": "2026-10-23",
"completion_date": "2029-03-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05156398",
"publication_url": "https://clinicaltrials.gov/study/NCT05156398",
"title": "A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant in Migraine Prevention in Children and Adolescents ≥ 6 to <18 Years of Age",
"has_exemption": false,
"start_date": "2022-02-28",
"completion_date": "2029-03-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06905132",
"publication_url": "https://clinicaltrials.gov/study/NCT06905132",
"title": "Preoperative 5-Day Radiotherapy for Soft Tissue Sarcoma: A Single Institution Phase II Trial",
"has_exemption": false,
"start_date": "2025-04-01",
"completion_date": "2029-03-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06843447",
"publication_url": "https://clinicaltrials.gov/study/NCT06843447",
"title": "A Phase 1b/2 Open-label, Multicenter Study to Evaluate the Safety and Efficacy of Raludotatug Deruxtecan With or Without Other Anticancer Investigational Agents in Participants With Advanced High-Grade Serous or High-Grade Endometrioid Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (REJOICE-Ovarian02)",
"has_exemption": false,
"start_date": "2025-04-15",
"completion_date": "2029-03-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07507643",
"publication_url": "https://clinicaltrials.gov/study/NCT07507643",
"title": "A Randomized Controlled Trial of Methylprednisolone Versus Standard of Care in Patients Undergoing Major Hepatectomy",
"has_exemption": false,
"start_date": "2026-03-27",
"completion_date": "2029-03-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06347705",
"publication_url": "https://clinicaltrials.gov/study/NCT06347705",
"title": "Phase II Study Evaluating the Effects of Single Site Intratumoral Injections of Anti-CD40 Agonist Antibody (2141-V11) Given as Monotherapy Prior to Radical Prostatectomy to Men With Intermediate Risk Disease and in Combination With Androgen Deprivation Therapy for Those With High Risk Localized and Low Volume Metastatic Disease",
"has_exemption": false,
"start_date": "2024-03-28",
"completion_date": "2029-03-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07037862",
"publication_url": "https://clinicaltrials.gov/study/NCT07037862",
"title": "A 2-Part, Randomized, Double-Blind, Placebo-Controlled Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping With an Initial Multiple Ascending Dose Part A to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ENTR-601-44, Followed by Part B to Evaluate the Safety and Efficacy of ENTR-601-44 (ELEVATE-44)",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2029-03-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Entrada Therapeutics, Inc.",
"sponsor_slug": "entrada-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06997497",
"publication_url": "https://clinicaltrials.gov/study/NCT06997497",
"title": "A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084, Cetuximab, and mFOLFOX6 Versus mFOLFOX6 With or Without Bevacizumab as First-line Treatment of Participants With KRAS G12C-mutant, Locally Advanced Unresectable or Metastatic Colorectal Cancer (KANDLELIT-012)",
"has_exemption": false,
"start_date": "2025-07-16",
"completion_date": "2029-03-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07430956",
"publication_url": "https://clinicaltrials.gov/study/NCT07430956",
"title": "A Master Protocol for a Phase 3, Randomized, Multicenter, Double-blind Study to Assess Stroke and Systemic Embolism Prevention With REGN7508 and REGN9933, Monoclonal Antibodies Against Factor XI, Versus Placebo in Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable (ROXI-INCLINE)",
"has_exemption": false,
"start_date": "2026-04-03",
"completion_date": "2029-03-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07192614",
"publication_url": "https://clinicaltrials.gov/study/NCT07192614",
"title": "A Phase I/II Open-label, Dose Escalation and Dose Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of AZD6621, a T Cell-engaging Antibody That Targets STEAP2, CD3, and CD8 in Adult Participants With Metastatic Prostate Cancer",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2029-03-29",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03075696",
"publication_url": "https://clinicaltrials.gov/study/NCT03075696",
"title": "A Multicenter, Open-label, Phase I/II Study to Evaluate the Safety, Efficacy, Tolerability and Pharmacokinetics of Escalating Doses of Glofitamab (RO7082859) as a Single Agent and in Combination With Obinutuzumab Administered After a Fixed, Single Dose Pre-treatment of Obinutuzumab (Gazyva®/Gazyvaro™) in Patients With Relapsed/Refractory B-cell Non-hodgkin's Lymphoma",
"has_exemption": false,
"start_date": "2017-02-21",
"completion_date": "2029-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07046910",
"publication_url": "https://clinicaltrials.gov/study/NCT07046910",
"title": "Advanced Immunoclinical Phenotyping of Rejection in Lung Transplant",
"has_exemption": false,
"start_date": "2019-04-01",
"completion_date": "2029-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Virginia",
"sponsor_slug": "university-of-virginia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04752774",
"publication_url": "https://clinicaltrials.gov/study/NCT04752774",
"title": "An Integrated Phase I/II, Multicentre, Double-blind, Randomised, Dysport and Placebo-controlled, Dose Escalation and Dose-finding Study to Evaluate the Safety and Efficacy of IPN10200 in the Treatment of Adult Upper Limb Spasticity.",
"has_exemption": false,
"start_date": "2021-04-29",
"completion_date": "2029-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Ipsen",
"sponsor_slug": "ipsen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05651594",
"publication_url": "https://clinicaltrials.gov/study/NCT05651594",
"title": "A Phase 2 Trial of Chemotherapy, Pembrolizumab, and Propranolol in Advanced Esophageal/Gastroesophageal Junction Adenocarcinoma Patients",
"has_exemption": false,
"start_date": "2023-03-07",
"completion_date": "2029-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Roswell Park Cancer Institute",
"sponsor_slug": "roswell-park-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06778434",
"publication_url": "https://clinicaltrials.gov/study/NCT06778434",
"title": "Acid Sphingomyelinase Inhibition to Mitigate the Environmental Exposure Risks of Ultraviolet Light-Induced Actinic Neoplasia and Squamous Cell Carcinoma in US Veterans",
"has_exemption": false,
"start_date": "2025-04-01",
"completion_date": "2029-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06918431",
"publication_url": "https://clinicaltrials.gov/study/NCT06918431",
"title": "A Phase 2 Study Evaluating the Safety and Efficacy of Asparaginase Erwinia Chrysanthemi- Recombinant-Rywn (Recombinant Erwinia Asparaginase) During Pediatric-Inspired Regimen in High-Risk Adults With Newly Diagnosed ALL or LBL",
"has_exemption": false,
"start_date": "2025-10-10",
"completion_date": "2029-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07768371",
"publication_url": "https://clinicaltrials.gov/study/NCT07768371",
"title": "A 52-week Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess Efficacy and Safety of Remibrutinib (LOU064) in Adult and Adolescent Participants With IgE-mediated Food Allergy",
"has_exemption": false,
"start_date": "2026-08-27",
"completion_date": "2029-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07169617",
"publication_url": "https://clinicaltrials.gov/study/NCT07169617",
"title": "Evaluating the Feasibility of a Survivin Peptide Vaccine (SurVaxM) as an Interception Agent in Patients at High Risk for Lung Cancer",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2029-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07775287",
"publication_url": "https://clinicaltrials.gov/study/NCT07775287",
"title": "A Randomized, Open-label, Phase 3 Trial of Petosemtamab + FOLFIRI/mFOLFOX6 Versus Cetuximab or Bevacizumab + FOLFIRI/mFOLFOX6 as Second-line Treatment in Participants With RAS and BRAF Wild-type, Recurrent, Unresectable or Metastatic Colorectal Cancer",
"has_exemption": false,
"start_date": "2026-10-07",
"completion_date": "2029-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Genmab",
"sponsor_slug": "genmab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07653243",
"publication_url": "https://clinicaltrials.gov/study/NCT07653243",
"title": "A Randomized, Sham-Controlled Trial of Home-Based Lower-Extremity Heat Therapy in Adults With Peripheral Artery Disease",
"has_exemption": false,
"start_date": "2027-01-01",
"completion_date": "2029-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Aquilo Sports, LLC",
"sponsor_slug": "aquilo-sports-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07349693",
"publication_url": "https://clinicaltrials.gov/study/NCT07349693",
"title": "A Randomized Trial to Assess the Efficacy and Safety of Cerebraca Wafer Plus Temozolomide Versus Temozolomide Alone in Recurrent Glioblastoma",
"has_exemption": false,
"start_date": "2027-04-01",
"completion_date": "2029-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Everfront Biotech Co., Ltd.",
"sponsor_slug": "everfront-biotech-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00185744",
"publication_url": "https://clinicaltrials.gov/study/NCT00185744",
"title": "Accelerated Partial Breast Irradiation Following Lumpectomy for Breast Cancer",
"has_exemption": false,
"start_date": "2002-09-30",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02716246",
"publication_url": "https://clinicaltrials.gov/study/NCT02716246",
"title": "Phase I/II/III Gene Transfer Clinical Trial of scAAV9.U1a.hSGSH for Mucopolysaccharidosis (MPS) IIIA",
"has_exemption": false,
"start_date": "2016-04-25",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ultragenyx Pharmaceutical Inc",
"sponsor_slug": "ultragenyx-pharmaceutical-inc",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03153475",
"publication_url": "https://clinicaltrials.gov/study/NCT03153475",
"title": "Multi-Center Clinical Evaluation of the ATTUNE® Revision System in Revision Total Knee Arthroplasty",
"has_exemption": false,
"start_date": "2017-05-30",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "DePuy Orthopaedics",
"sponsor_slug": "depuy-orthopaedics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03167203",
"publication_url": "https://clinicaltrials.gov/study/NCT03167203",
"title": "A Safety Surveillance Study of Events of Special Interest Occurring in Subjects With Macular Degenerative Disease Treated With Human Embryonic Stem Cell-derived Retinal Pigment Epithelial Cell Therapy",
"has_exemption": false,
"start_date": "2018-01-08",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Astellas Institute for Regenerative Medicine",
"sponsor_slug": "astellas-institute-for-regenerative-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03493425",
"publication_url": "https://clinicaltrials.gov/study/NCT03493425",
"title": "Phase II Randomized Trial of Neoadjuvant Chemotherapy Followed by Surgery and Post-Operative Radiation Versus Surgery and Post-Operative Radiation for Organ Preservation of T3 and T4a (and Selected T4b) Nasal and Paranasal Sinus Squamous Cell Carcinoma (NPNSCC)",
"has_exemption": false,
"start_date": "2019-03-12",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ECOG-ACRIN Cancer Research Group",
"sponsor_slug": "ecog-acrin-cancer-research-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04740476",
"publication_url": "https://clinicaltrials.gov/study/NCT04740476",
"title": "An Open-Label Extension Study for Patients With Dravet Syndrome Who Previously Participated in Studies of STK-001",
"has_exemption": false,
"start_date": "2021-01-20",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stoke Therapeutics, Inc",
"sponsor_slug": "stoke-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04786223",
"publication_url": "https://clinicaltrials.gov/study/NCT04786223",
"title": "Targeting Neuroinflammation as a Contributing Pathology in Alzheimer's Disease Dementia and Related Dementias",
"has_exemption": false,
"start_date": "2021-03-30",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Val Lowe",
"sponsor_slug": "val-lowe",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04848506",
"publication_url": "https://clinicaltrials.gov/study/NCT04848506",
"title": "A Follow-Up, Open-Label, Research Evaluation of Sustained Treatment With Aficamten (CK-3773274) in Hypertrophic Cardiomyopathy (HCM)",
"has_exemption": false,
"start_date": "2021-05-06",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Cytokinetics",
"sponsor_slug": "cytokinetics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04884815",
"publication_url": "https://clinicaltrials.gov/study/NCT04884815",
"title": "An Operationally Seamless Phase 1/2/3 Study Consisting of a Safety and Dose-finding Phase 1/2 and Randomized, Open-label, Active-controlled Phase 3 to Evaluate UX701 AAV Gene Therapy in Adults With Wilson Disease",
"has_exemption": false,
"start_date": "2021-09-27",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ultragenyx Pharmaceutical Inc",
"sponsor_slug": "ultragenyx-pharmaceutical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05127226",
"publication_url": "https://clinicaltrials.gov/study/NCT05127226",
"title": "HALOS: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intrathecally Administered ION582 in Patients With Angelman Syndrome",
"has_exemption": false,
"start_date": "2021-12-22",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ionis Pharmaceuticals, Inc.",
"sponsor_slug": "ionis-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04831580",
"publication_url": "https://clinicaltrials.gov/study/NCT04831580",
"title": "A Randomized Controlled Trial of Robotic Versus Open Surgery for Early Stage Cervical Cancer (ROCC)",
"has_exemption": false,
"start_date": "2022-03-22",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "GOG Foundation",
"sponsor_slug": "gog-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05595473",
"publication_url": "https://clinicaltrials.gov/study/NCT05595473",
"title": "A Phase 1/2a, Open-label, Multicenter, Dose Escalation and Dose Expansion Study Evaluating the Safety, Tolerability and Efficacy of RZ-001 in Combination with Valganciclovir in Subjects with Hepatocellular Carcinoma",
"has_exemption": false,
"start_date": "2022-07-29",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rznomics, Inc.",
"sponsor_slug": "rznomics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05604131",
"publication_url": "https://clinicaltrials.gov/study/NCT05604131",
"title": "Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients",
"has_exemption": false,
"start_date": "2022-11-08",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rohan Dharmakumar",
"sponsor_slug": "rohan-dharmakumar",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05619146",
"publication_url": "https://clinicaltrials.gov/study/NCT05619146",
"title": "Upper and Lower Extremity Cycling in Incomplete Spinal Cord Injury Individuals to Promote Limb Recovery",
"has_exemption": false,
"start_date": "2023-01-23",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Shirley Ryan AbilityLab",
"sponsor_slug": "shirley-ryan-abilitylab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05462145",
"publication_url": "https://clinicaltrials.gov/study/NCT05462145",
"title": "A Prospective, Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation",
"has_exemption": false,
"start_date": "2023-03-09",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Kardium Inc.",
"sponsor_slug": "kardium-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05721755",
"publication_url": "https://clinicaltrials.gov/study/NCT05721755",
"title": "Phase III Randomized Trial of Immunotherapy With or Without Consolidative Radiotherapy for Oligometastatic Head and Neck Squamous Cell Carcinoma",
"has_exemption": false,
"start_date": "2023-06-08",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ECOG-ACRIN Cancer Research Group",
"sponsor_slug": "ecog-acrin-cancer-research-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05608408",
"publication_url": "https://clinicaltrials.gov/study/NCT05608408",
"title": "Network Neuro-modulation for Mesial Temporal Lobe Epilepsy",
"has_exemption": false,
"start_date": "2023-11-16",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Nitin Tandon",
"sponsor_slug": "nitin-tandon",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05172973",
"publication_url": "https://clinicaltrials.gov/study/NCT05172973",
"title": "Safety and Effectiveness of Balloon-Expandable Bioprosthetic SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves",
"has_exemption": false,
"start_date": "2023-11-22",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Edwards Lifesciences",
"sponsor_slug": "edwards-lifesciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06053567",
"publication_url": "https://clinicaltrials.gov/study/NCT06053567",
"title": "Efficacy and Implementation of Exercise-based Smoking Cessation Treatment for Adults With High Anxiety Sensitivity.",
"has_exemption": false,
"start_date": "2023-12-27",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Jasper A. Smits",
"sponsor_slug": "jasper-a-smits",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06305286",
"publication_url": "https://clinicaltrials.gov/study/NCT06305286",
"title": "A Pilot Study Assessing the Safety of Using a Monoclonal Antibody Against Cluster of Differentiation 40 (CD40) Ligand to Achieve a Calcineurin Inhibitor-free Immunosuppression Regimen in Patients With Type 1 Diabetes Mellitus (T1D) and Problematic Hypoglycemia Undergoing Islet Cell Transplantation",
"has_exemption": false,
"start_date": "2024-03-04",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06292013",
"publication_url": "https://clinicaltrials.gov/study/NCT06292013",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) Who Have Established Atherosclerotic Cardiovascular Disease or Are at Risk for a First Cardiovascular Event - ACCLAIM-Lp(a)",
"has_exemption": false,
"start_date": "2024-03-05",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06350318",
"publication_url": "https://clinicaltrials.gov/study/NCT06350318",
"title": "A Phase 2 Open-Label, Multicenter Study of Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas",
"has_exemption": false,
"start_date": "2024-04-19",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05977400",
"publication_url": "https://clinicaltrials.gov/study/NCT05977400",
"title": "NICU Antibiotics and Outcomes Follow-Up Study",
"has_exemption": false,
"start_date": "2024-04-30",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sharp HealthCare",
"sponsor_slug": "sharp-healthcare",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05866562",
"publication_url": "https://clinicaltrials.gov/study/NCT05866562",
"title": "Dupilumab in the Treatment of Pediatric Alopecia Areata",
"has_exemption": false,
"start_date": "2024-07-11",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Icahn School of Medicine at Mount Sinai",
"sponsor_slug": "icahn-school-of-medicine-at-mount-sinai",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06395103",
"publication_url": "https://clinicaltrials.gov/study/NCT06395103",
"title": "LIGHTBEAM-U01 Substudy 01A: A Phase 1/2 Substudy to Evaluate the Safety and Efficacy of Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors",
"has_exemption": false,
"start_date": "2024-08-16",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06102525",
"publication_url": "https://clinicaltrials.gov/study/NCT06102525",
"title": "A Phase 1/2a, Open-label, Multicenter, Dose Escalation and Dose Expansion Study Evaluating the Safety, Tolerability, and Efficacy of RZ-001 in Combination With Valganciclovir in Subjects With Glioblastoma",
"has_exemption": false,
"start_date": "2024-10-08",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rznomics, Inc.",
"sponsor_slug": "rznomics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06798558",
"publication_url": "https://clinicaltrials.gov/study/NCT06798558",
"title": "Phase II Study of Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy",
"has_exemption": false,
"start_date": "2025-03-05",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hackensack Meridian Health",
"sponsor_slug": "hackensack-meridian-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06542705",
"publication_url": "https://clinicaltrials.gov/study/NCT06542705",
"title": "Effect of Internal Brace on Outcomes Following ACL Reconstruction With Bone Patellar Bone (BTB) Autograft: A Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2025-03-17",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06647953",
"publication_url": "https://clinicaltrials.gov/study/NCT06647953",
"title": "Prospective Treatment of Types I, II and III Pleuropulmonary Blastoma (PPB)",
"has_exemption": false,
"start_date": "2025-03-21",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06880770",
"publication_url": "https://clinicaltrials.gov/study/NCT06880770",
"title": "Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Plozasiran in Adults With Severe Hypertriglyceridemia at High Risk of Acute Pancreatitis (SHASTA-5 Study)",
"has_exemption": false,
"start_date": "2025-04-24",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Arrowhead Pharmaceuticals",
"sponsor_slug": "arrowhead-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06682793",
"publication_url": "https://clinicaltrials.gov/study/NCT06682793",
"title": "A Seamless Phase 1/2 Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated Tmod™ CAR T, in Heterozygous HLA-A*02 Adults With Recurrent Unresectable, Locally Advanced, or Metastatic Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression",
"has_exemption": false,
"start_date": "2025-05-22",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "A2 Biotherapeutics Inc.",
"sponsor_slug": "a2-biotherapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06839235",
"publication_url": "https://clinicaltrials.gov/study/NCT06839235",
"title": "A Phase 1/2 Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of ABO-101 in Participants With Primary Hyperoxaluria Type 1 (PH1)",
"has_exemption": false,
"start_date": "2025-06-16",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Arbor Biotechnologies",
"sponsor_slug": "arbor-biotechnologies",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06757634",
"publication_url": "https://clinicaltrials.gov/study/NCT06757634",
"title": "VIKTORIA-2: A Randomized, Open-Label, Phase 3 Study Evaluating Efficacy and Safety of Gedatolisib With Endocrine Therapy and Palbociclib vs Endocrine Therapy and Ribociclib as First-Line Treatment in Patients With HR-Positive and HER2-Negative Advanced Breast Cancer",
"has_exemption": false,
"start_date": "2025-07-24",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Celcuity, Inc.",
"sponsor_slug": "celcuity-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07098988",
"publication_url": "https://clinicaltrials.gov/study/NCT07098988",
"title": "A Ph2, Randomized, Blinded, Placebo-Controlled Trial Investigating the Efficacy and Safety of Visugromab Versus Placebo, in Combination With Pembrolizumab, Pemetrexed, and Carboplatin, in 1L Treatment of Participants With Metastatic NSCLC (GDFATHER-NSCLC-01)",
"has_exemption": false,
"start_date": "2025-08-01",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "CatalYm GmbH",
"sponsor_slug": "catalym-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07145736",
"publication_url": "https://clinicaltrials.gov/study/NCT07145736",
"title": "Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Tropical Diseases: A Cluster-randomised Trial",
"has_exemption": false,
"start_date": "2025-08-04",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Kirby Institute",
"sponsor_slug": "kirby-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07016698",
"publication_url": "https://clinicaltrials.gov/study/NCT07016698",
"title": "A Prospective, Multicenter, Single Arm, Real-World Registry Assessing the Clinical Use of the Rotarex(TM) Rotational Excisional Atherectomy System (XTRACT Registry)",
"has_exemption": false,
"start_date": "2025-09-29",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "C. R. Bard",
"sponsor_slug": "c-r-bard",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07132918",
"publication_url": "https://clinicaltrials.gov/study/NCT07132918",
"title": "The cARdiac Radiation Therapy Sparing (HEARTS) for Thoracic Cancers",
"has_exemption": false,
"start_date": "2025-10-08",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Wisconsin, Madison",
"sponsor_slug": "university-of-wisconsin-madison",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07218783",
"publication_url": "https://clinicaltrials.gov/study/NCT07218783",
"title": "A Prospective, Multicenter, Randomized, Masked, Controlled Study to Evaluate the Safety and Efficacy of the Bimatoprost Implant System (78 mcg) Used in Combination With the SpyGlass IOL Compared to Timolol Maleate Ophthalmic Solution, USP, 0.5%,",
"has_exemption": false,
"start_date": "2025-10-15",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "SpyGlass Pharma, Inc.",
"sponsor_slug": "spyglass-pharma-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07135050",
"publication_url": "https://clinicaltrials.gov/study/NCT07135050",
"title": "Phase 1/2 First-in-Human Study to Evaluate the Safety, Tolerability, and Efficacy of MZ-1866, an AAV-9 Gene Therapy Delivered by Intracerebroventricular Injection to Participants With Pitt Hopkins Syndrome",
"has_exemption": false,
"start_date": "2025-12-19",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mahzi Therapeutics",
"sponsor_slug": "mahzi-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07209332",
"publication_url": "https://clinicaltrials.gov/study/NCT07209332",
"title": "An Open-Label Extension Study to Investigate the Long-term Safety, Tolerability, Pharmacokinetics, and Efficacy of WVE-N531 in Patients With Duchenne Muscular Dystrophy Who Participated in Another Study of WVE-N531",
"has_exemption": false,
"start_date": "2025-12-28",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Wave Life Sciences USA, Inc.",
"sponsor_slug": "wave-life-sciences-usa-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07262619",
"publication_url": "https://clinicaltrials.gov/study/NCT07262619",
"title": "A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors, Including Checkpoint Inhibitor Naïve Participants With Microsatellite Instability High (MSI-H) or Mismatch Repair Deficient (dMMR) Tumors",
"has_exemption": false,
"start_date": "2026-01-20",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eikon Therapeutics",
"sponsor_slug": "eikon-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06155682",
"publication_url": "https://clinicaltrials.gov/study/NCT06155682",
"title": "Cognitive and Neural Correlates of TMS Motor Intracortical Inhibition in Schizophrenia",
"has_exemption": false,
"start_date": "2026-02-02",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Maryland, Baltimore",
"sponsor_slug": "university-of-maryland-baltimore",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07450859",
"publication_url": "https://clinicaltrials.gov/study/NCT07450859",
"title": "A Phase 2 Study of BT5528 in Patients With Metastatic Pancreatic Ductal Adenocarcinoma",
"has_exemption": false,
"start_date": "2026-03-05",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "BicycleTx Limited",
"sponsor_slug": "bicycletx-limited",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07436689",
"publication_url": "https://clinicaltrials.gov/study/NCT07436689",
"title": "A Multicenter, Open-Label, Long-Term Extension Study for Oral Levosimendan (TNX-103)",
"has_exemption": false,
"start_date": "2026-03-13",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Tenax Therapeutics, Inc.",
"sponsor_slug": "tenax-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07459660",
"publication_url": "https://clinicaltrials.gov/study/NCT07459660",
"title": "An Open-Label Study to Assess the Long-Term Safety and Tolerability of ML007C-MA in Adult Participants With Hallucinations and Delusions Associated With Alzheimer's Disease Psychosis",
"has_exemption": false,
"start_date": "2026-03-25",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "MapLight Therapeutics",
"sponsor_slug": "maplight-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07485738",
"publication_url": "https://clinicaltrials.gov/study/NCT07485738",
"title": "Surgical Measurement for Accurate Revascularization Using Transit-time FLOW (SMARTFLOW):Patency",
"has_exemption": false,
"start_date": "2026-03-30",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Weill Medical College of Cornell University",
"sponsor_slug": "weill-medical-college-of-cornell-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06240455",
"publication_url": "https://clinicaltrials.gov/study/NCT06240455",
"title": "A Double-blind, Placebo-controlled, Phase 2 Dose-range Study to Assess the Efficacy and Safety of WP1302 in Preventing Disease Relapse Following Methimazole Withdrawal in Subjects With Graves' Disease",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Worg Biotherapeutics Inc.",
"sponsor_slug": "worg-biotherapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06782542",
"publication_url": "https://clinicaltrials.gov/study/NCT06782542",
"title": "Single-Arm Phase 2 Study of Olutasidenib, Venetoclax, and Azacitidine in IDH1 Mutated Newly Diagnosed Acute Myeloid Leukemia Patients Who Are Eligible for Intensive Induction Chemotherapy",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Justin Watts, MD",
"sponsor_slug": "justin-watts-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07439653",
"publication_url": "https://clinicaltrials.gov/study/NCT07439653",
"title": "A Phase 1/2, First-in-Human, Open-Label, Multicenter Study of TORL-5-700 as a Monotherapy and in Combination for Participants With Relapsed or Refractory Non-Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "TORL Biotherapeutics, LLC",
"sponsor_slug": "torl-biotherapeutics-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07547878",
"publication_url": "https://clinicaltrials.gov/study/NCT07547878",
"title": "A Pilot Randomized Clinical Trial to Assess Feasibility, Safety, and Efficacy of Rapid, Simultaneous Therapy Initiation in Chronic Kidney Disease and Type 2 Diabetes: RAPID-CKD",
"has_exemption": false,
"start_date": "2026-04-08",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Baylor Research Institute",
"sponsor_slug": "baylor-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07227207",
"publication_url": "https://clinicaltrials.gov/study/NCT07227207",
"title": "A Phase 1/2, Open-Label, Multi-Center, Dose Escalation, Dose Expansion, and Single Repeat Dose Study of TSRA-196 in Adults With the PiZZ Genotype Who Have Lung and/or Liver Disease Associated With Severe Alpha-1 Antitrypsin Deficiency",
"has_exemption": false,
"start_date": "2026-04-21",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Tessera Therapeutics, Inc.",
"sponsor_slug": "tessera-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07288437",
"publication_url": "https://clinicaltrials.gov/study/NCT07288437",
"title": "Adaptive Deep Brain Stimulation Targeting the Dentate Nucleus to Treat Spinocerebellar Ataxia",
"has_exemption": false,
"start_date": "2026-04-27",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06844383",
"publication_url": "https://clinicaltrials.gov/study/NCT06844383",
"title": "A Randomized Open-label Phase 2 Study of TALazoparib With or Without ENzaluTamide in Patients With Metastatic Castration-Resistant Prostate Cancer and HRR Mutations After Progression on Abiraterone Acetate or Darolutamide",
"has_exemption": false,
"start_date": "2026-05-04",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Prostate Cancer Clinical Trials Consortium",
"sponsor_slug": "prostate-cancer-clinical-trials-consortium",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07514338",
"publication_url": "https://clinicaltrials.gov/study/NCT07514338",
"title": "An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of KL1333 (Napazimone) in Patients With Primary Mitochondrial Disease",
"has_exemption": false,
"start_date": "2026-06-12",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Pharming Technologies B.V.",
"sponsor_slug": "pharming-technologies-bv",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07605429",
"publication_url": "https://clinicaltrials.gov/study/NCT07605429",
"title": "A Randomized, Multi-center, Double-blind, Sham-controlled, Phase III Clinical Study to Evaluate the Efficacy and Safety of Intrathecally Administered Rugonersen in Pediatric and Adult Participants With Angelman Syndrome",
"has_exemption": false,
"start_date": "2026-06-23",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "OHB Pediatrics Ltd.",
"sponsor_slug": "ohb-pediatrics-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07683000",
"publication_url": "https://clinicaltrials.gov/study/NCT07683000",
"title": "A Phase 3, Randomized, Open-label Study to Evaluate the Efficacy and Safety of Switching to a Regimen of Broadly Neutralizing Antibodies Teropavimab and Zinlirvimab in Combination With Capsid Inhibitor Lenacapavir Twice-Yearly in Virologically Suppressed Adults With HIV-1 on Stable Oral Treatment Regimens",
"has_exemption": false,
"start_date": "2026-07-14",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Gilead Sciences",
"sponsor_slug": "gilead-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07682961",
"publication_url": "https://clinicaltrials.gov/study/NCT07682961",
"title": "A Phase 3, Randomized, Open-label Study to Evaluate the Efficacy and Safety of Switching to Long-acting Antiretroviral Therapy of Broadly Neutralizing Antibodies Teropavimab and Zinlirvimab in Combination With the Capsid Inhibitor Lenacapavir Twice-Yearly Versus Cabotegravir and Rilpivirine Every 8 Weeks in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy",
"has_exemption": false,
"start_date": "2026-07-14",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Gilead Sciences",
"sponsor_slug": "gilead-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07494084",
"publication_url": "https://clinicaltrials.gov/study/NCT07494084",
"title": "Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance",
"has_exemption": false,
"start_date": "2026-07-16",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington State University",
"sponsor_slug": "washington-state-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07218354",
"publication_url": "https://clinicaltrials.gov/study/NCT07218354",
"title": "CSP #2041 - Cessation or Reduction of Alcohol Consumption in VEterans: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate the Efficacy and Safety of a GLP-1 Receptor Agonist Semaglutide in U.S. Veterans With Alcohol Use Disorder (CRAVE)",
"has_exemption": false,
"start_date": "2026-07-28",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07740941",
"publication_url": "https://clinicaltrials.gov/study/NCT07740941",
"title": "NeoAdjuvant, Spare-Adjuvant (NASA) in Stage IIIB- IV (M1a) Melanoma",
"has_exemption": false,
"start_date": "2026-08-06",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "UNC Lineberger Comprehensive Cancer Center",
"sponsor_slug": "unc-lineberger-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07805954",
"publication_url": "https://clinicaltrials.gov/study/NCT07805954",
"title": "A Phase 3, Randomized, Open-Label Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Patients With Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma",
"has_exemption": false,
"start_date": "2026-08-28",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Revolution Medicines, Inc.",
"sponsor_slug": "revolution-medicines-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07734636",
"publication_url": "https://clinicaltrials.gov/study/NCT07734636",
"title": "A Prompt REstart Study of Renin-Angiotensin System Inhibitors After Acute Kidney Injury",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07517133",
"publication_url": "https://clinicaltrials.gov/study/NCT07517133",
"title": "A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Efficacy, Pharmacokinetics, and Safety of Mitapivat in Pediatric Subjects With α- or β-Non-Transfusion-Dependent Thalassemia",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Agios Pharmaceuticals, Inc.",
"sponsor_slug": "agios-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07696975",
"publication_url": "https://clinicaltrials.gov/study/NCT07696975",
"title": "RELIEVE-HFrEF TRIAL: REducing Lung congestIon Symptoms Using the v-wavE Shunt in adVancEd Heart Failure With Reduced EF",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "V-Wave Ltd",
"sponsor_slug": "v-wave-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07698613",
"publication_url": "https://clinicaltrials.gov/study/NCT07698613",
"title": "BrUOG 438: EGFR Targeted Photoimmunotherapy With ASP-1929 for Locally Advanced Pancreatic Cancer",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Brown University",
"sponsor_slug": "brown-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07777848",
"publication_url": "https://clinicaltrials.gov/study/NCT07777848",
"title": "A Randomized, Controlled, Multicenter Clinical Study to Evaluate the Efficacy and Safety of RAG-01 Monotherapy and RAG-01 in Combination With Chemotherapy in Intermediate/High-risk Patients With Non-muscle Invasive Bladder Cancer (NMIBC).",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ractigen Therapeutics.",
"sponsor_slug": "ractigen-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07781774",
"publication_url": "https://clinicaltrials.gov/study/NCT07781774",
"title": "Improving Colorectal Cancer Screening Uptake Through Patient-Centered Education and Mailed Stool-Based Testing Outreach in the Primary Care Medicine Clinic",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07793994",
"publication_url": "https://clinicaltrials.gov/study/NCT07793994",
"title": "Pedi-STAR: Surface Target Antibody-drug Conjugate (ADC) Antigen Expression in Relapsed/Refractory Pediatric Solid and CNS Tumors",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Dana-Farber Cancer Institute",
"sponsor_slug": "dana-farber-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07820085",
"publication_url": "https://clinicaltrials.gov/study/NCT07820085",
"title": "A Phase 2b/3, Quadruple-Blinded, Randomized, Placebo-Controlled Study of PORT-77 Administered Orally to Adults and Adolescents With Erythropoietic Protoporphyria or X-Linked Protoporphyria and an Open-Label Extension",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Portal Therapeutics, Inc.",
"sponsor_slug": "portal-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07060417",
"publication_url": "https://clinicaltrials.gov/study/NCT07060417",
"title": "The Effects of SGLT2 Inhibition on Vascular Health and Physical Function in Veterans With CKD",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07110233",
"publication_url": "https://clinicaltrials.gov/study/NCT07110233",
"title": "Prospective Phase 2 Trial of Yttrium-90 Radiation Segmentectomy for Unresectable Hepatocellular Carcinoma",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07871435",
"publication_url": "https://clinicaltrials.gov/study/NCT07871435",
"title": "A Phase 1b/2, Open-label, Multi-center Study to Evaluate the Anti-cancer Activity, Safety and Tolerability of GI-102 (CD80-IgG4 Fc-IL2v3) in Combination With Pasritamig [T-CELL-Redirecting Agent Targeting Human Kallikrein 2 (KLK2)] in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) Who Progressed on Previous Novel Hormonal Therapy (NHT) (JET-201)",
"has_exemption": false,
"start_date": "2026-10-12",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "GI Innovation, Inc.",
"sponsor_slug": "gi-innovation-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06855043",
"publication_url": "https://clinicaltrials.gov/study/NCT06855043",
"title": "Pilot Randomized Controlled Trial of Late Surfactant Therapy With Budesonide for Prevention of Bronchopulmonary Dysplasia",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Wisconsin, Madison",
"sponsor_slug": "university-of-wisconsin-madison",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07835581",
"publication_url": "https://clinicaltrials.gov/study/NCT07835581",
"title": "A Multicenter, Phase 3 Randomized, Active-Controlled, Open-Label Study to Evaluate the Efficacy and Safety of Tegoprubart Compared With Tacrolimus in Adult Participants Undergoing De Novo Kidney Transplantation",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eledon Pharmaceuticals",
"sponsor_slug": "eledon-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07847918",
"publication_url": "https://clinicaltrials.gov/study/NCT07847918",
"title": "A Site-Less Feasibility Trial of Phenylbutyrate for SLC6A1-Related Disorders",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Scripps Translational Science Institute",
"sponsor_slug": "scripps-translational-science-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07864558",
"publication_url": "https://clinicaltrials.gov/study/NCT07864558",
"title": "PrEcision Pacing in HFpEF: the PEP-HFpEF Trial",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Tufts Medical Center",
"sponsor_slug": "tufts-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07672782",
"publication_url": "https://clinicaltrials.gov/study/NCT07672782",
"title": "Phase II Study Tisotumab Vedotin in Metastatic or Recurrent Squamous Cell Carcinoma of the Vulva",
"has_exemption": false,
"start_date": "2026-11-30",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "GOG Foundation",
"sponsor_slug": "gog-foundation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07639606",
"publication_url": "https://clinicaltrials.gov/study/NCT07639606",
"title": "Mobile Cognitive Behavioral Therapy in Early Stroke Recovery",
"has_exemption": false,
"start_date": "2026-11-30",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Weill Medical College of Cornell University",
"sponsor_slug": "weill-medical-college-of-cornell-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07596914",
"publication_url": "https://clinicaltrials.gov/study/NCT07596914",
"title": "Assessing Multi-site Feasibility of an Integrated Whole-body Hyperthermia and Behavioral Intervention for Major Depressive Disorder: The MULTIBED Study",
"has_exemption": false,
"start_date": "2026-12-01",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07572123",
"publication_url": "https://clinicaltrials.gov/study/NCT07572123",
"title": "A Two Cohort Randomized Study for Patients With High Risk (Phase II) and Standard Risk (Phase III) Classical Hodgkin Lymphoma in First Relapse",
"has_exemption": false,
"start_date": "2026-12-04",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07104318",
"publication_url": "https://clinicaltrials.gov/study/NCT07104318",
"title": "Randomized Clinical Trial of Personalized vs Standard of Care Treatment for Helicobacter Pylori Eradication Among Veterans: \"VA Eradicate HP\"",
"has_exemption": false,
"start_date": "2027-01-01",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07852195",
"publication_url": "https://clinicaltrials.gov/study/NCT07852195",
"title": "A Randomized Phase II/III Trial Evaluating Bipolar Androgen Therapy Followed by Darolutamide vs. Standard of Care in Patients With Metastatic Castration Resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2027-01-06",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "ECOG-ACRIN Cancer Research Group",
"sponsor_slug": "ecog-acrin-cancer-research-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06167213",
"publication_url": "https://clinicaltrials.gov/study/NCT06167213",
"title": "Safety and Effectiveness of Balloon-Expandable Bioprosthetic SAPIEN X4 Transcatheter Heart Valve - Mitral",
"has_exemption": false,
"start_date": "2027-01-31",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Edwards Lifesciences",
"sponsor_slug": "edwards-lifesciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07078838",
"publication_url": "https://clinicaltrials.gov/study/NCT07078838",
"title": "A Randomized, Window of Opportunity Trial of Tirzepatide in Women With Obesity and a Diagnosis of Endometrial Intra-epithelial Neoplasia (EIN) or Grade 1 Endometrial Cancer",
"has_exemption": false,
"start_date": "2027-01-31",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "UNC Lineberger Comprehensive Cancer Center",
"sponsor_slug": "unc-lineberger-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07634835",
"publication_url": "https://clinicaltrials.gov/study/NCT07634835",
"title": "Transcranial Magnetic Stimulation for Adolescents and Young Adults With Cannabis Use Disorder",
"has_exemption": false,
"start_date": "2027-03-01",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07463807",
"publication_url": "https://clinicaltrials.gov/study/NCT07463807",
"title": "Phase Ib/II Fixed Duration Study of Teclistamab/Pomalidomide (TP) Versus Carfilzomib/Pomalidomide/Dexamethasone (KPd) in Early Relapse of Multiple Myeloma",
"has_exemption": false,
"start_date": "2027-04-12",
"completion_date": "2029-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04682158",
"publication_url": "https://clinicaltrials.gov/study/NCT04682158",
"title": "Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma A Phase II Study",
"has_exemption": false,
"start_date": "2021-04-01",
"completion_date": "2029-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Roswell Park Cancer Institute",
"sponsor_slug": "roswell-park-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06499805",
"publication_url": "https://clinicaltrials.gov/study/NCT06499805",
"title": "Barriers and Facilitators to OTC Hearing Aids Success",
"has_exemption": false,
"start_date": "2025-03-15",
"completion_date": "2029-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Yu-Hsiang Wu",
"sponsor_slug": "yu-hsiang-wu",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06828991",
"publication_url": "https://clinicaltrials.gov/study/NCT06828991",
"title": "ctDNA-Guided Mosunetuzumab Consolidation Therapy in Older Patients With Untreated DLBCL",
"has_exemption": false,
"start_date": "2025-09-04",
"completion_date": "2029-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Danielle Wallace",
"sponsor_slug": "danielle-wallace",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06834217",
"publication_url": "https://clinicaltrials.gov/study/NCT06834217",
"title": "Characterization and Modulation of Functional Connectivity and Fear Extinction Abnormalities in Obsessive-Compulsive Disorder",
"has_exemption": false,
"start_date": "2025-09-12",
"completion_date": "2029-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06574009",
"publication_url": "https://clinicaltrials.gov/study/NCT06574009",
"title": "Better Options for Chronic Cancer Pain: a SMART Study",
"has_exemption": false,
"start_date": "2025-10-07",
"completion_date": "2029-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06743113",
"publication_url": "https://clinicaltrials.gov/study/NCT06743113",
"title": "A Multi-Center, Randomized, Controlled, Cross-Over Study to Evaluate the Effectiveness of Hypoxic Red Blood Cells Processed With the Hemanext ONE® System Versus Conventional Red Blood Cells in Patients With Transfusion Dependent Sickle Cell Anemia",
"has_exemption": false,
"start_date": "2026-09-01",
"completion_date": "2029-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Hemanext",
"sponsor_slug": "hemanext",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02199015",
"publication_url": "https://clinicaltrials.gov/study/NCT02199015",
"title": "Lateral Cord Electrical Stimulation Can Improve Spasticity in Chronic Spastic Cerebral Palsy",
"has_exemption": false,
"start_date": "2027-06-01",
"completion_date": "2029-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Juan Carlos M. Andreani MD",
"sponsor_slug": "juan-carlos-m-andreani-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05295290",
"publication_url": "https://clinicaltrials.gov/study/NCT05295290",
"title": "LOW INTERVENTIONAL COHORT STUDY OF MYOCARDITIS/PERICARDITIS ASSOCIATED WITH COMIRNATY IN PERSONS LESS THAN 21 YEARS OF AGE",
"has_exemption": false,
"start_date": "2022-11-21",
"completion_date": "2029-04-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07644039",
"publication_url": "https://clinicaltrials.gov/study/NCT07644039",
"title": "A Multicenter, Open-label, Phase 1/2 Safety Run-in and Expansion Study of PM54 in Combination With Immunotherapy Evaluating Safety and Efficacy in Adult Participants Who Were Previously Treated for Advanced Malignancies",
"has_exemption": false,
"start_date": "2026-05-21",
"completion_date": "2029-04-02",
"has_results": false,
"results_due": false,
"sponsor_name": "PharmaMar",
"sponsor_slug": "pharmamar",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07169734",
"publication_url": "https://clinicaltrials.gov/study/NCT07169734",
"title": "A Phase I/II, Open-label, Multicenter Study of ALE.P03 (Claudin-1 Targeted Antibody-drug Conjugate) as a Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors",
"has_exemption": false,
"start_date": "2025-08-26",
"completion_date": "2029-04-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Alentis Therapeutics AG",
"sponsor_slug": "alentis-therapeutics-ag",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07628049",
"publication_url": "https://clinicaltrials.gov/study/NCT07628049",
"title": "A Phase 1/2, Randomized, Controlled, Observer-blind, Multicentre Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of GSK Biologicals' Investigational Respiratory Syncytial Virus (RSV)/Human Metapneumovirus (hMPV) Combination and Investigational hMPV Vaccines When Administered Intramuscularly According to a Single Dose Schedule in Younger Adults ≥18 to ≤49 Years and Older Adults Aged ≥60 to ≤80 Years",
"has_exemption": false,
"start_date": "2026-06-05",
"completion_date": "2029-04-05",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07098338",
"publication_url": "https://clinicaltrials.gov/study/NCT07098338",
"title": "An Open-Label, Multi-Drug, Multi-Centre, Phase II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumour Activity of Novel Combinations in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (LIBRA)",
"has_exemption": false,
"start_date": "2025-08-07",
"completion_date": "2029-04-06",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05335928",
"publication_url": "https://clinicaltrials.gov/study/NCT05335928",
"title": "AbatacepT foR ImmUne Checkpoint Inhibitor Associated Myocarditis (ATRIUM): A Phase 3, Investigator-Initiated, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept in ICI Myocarditis",
"has_exemption": false,
"start_date": "2022-07-02",
"completion_date": "2029-04-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07823595",
"publication_url": "https://clinicaltrials.gov/study/NCT07823595",
"title": "A 16-WEEK, MULTICENTER, INTERVENTIONAL, PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO INVESTIGATE EFFICACY AND SAFETY OF ABROCITINIB IN CHILDREN 2 TO LESS THAN 6 YEARS OF AGE WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS",
"has_exemption": false,
"start_date": "2027-05-01",
"completion_date": "2029-04-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07504588",
"publication_url": "https://clinicaltrials.gov/study/NCT07504588",
"title": "A Randomized Phase II Trial of Sacituzumab Govitecan-HZIY (SG) and Bevacizumab Versus Standard of Care Carboplatin, Pegylated Liposomal Doxorubicin (PLD) and Bevacizumab in Patients With Platinum-Sensitive Ovarian Cancer That Has Progressed on Prior Maintenance PARP Inhibitor Therapy",
"has_exemption": false,
"start_date": "2026-09-24",
"completion_date": "2029-04-12",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07877194",
"publication_url": "https://clinicaltrials.gov/study/NCT07877194",
"title": "A Phase II Clinical Study of Ivonescimab in Combination With Cadonilimab or Ipilimumab in the Treatment of Advanced Renal Cancer",
"has_exemption": false,
"start_date": "2026-10-19",
"completion_date": "2029-04-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Summit Therapeutics",
"sponsor_slug": "summit-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07876128",
"publication_url": "https://clinicaltrials.gov/study/NCT07876128",
"title": "A Phase 1b/2, Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of MK-2750 in Participants With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2026-11-16",
"completion_date": "2029-04-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07215325",
"publication_url": "https://clinicaltrials.gov/study/NCT07215325",
"title": "The Effects of Doxycycline on Inflammation and the Microbiome: 'Flipping the Script' on STI PEP",
"has_exemption": false,
"start_date": "2025-10-13",
"completion_date": "2029-04-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Emory University",
"sponsor_slug": "emory-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07825064",
"publication_url": "https://clinicaltrials.gov/study/NCT07825064",
"title": "A Phase II, Single Arm, Open-Label, Multicenter Study Evaluating the Efficacy and Safety of Cevostamab in Combination With Pomalidomide and Dexamethasone in Patients With Multiple Myeloma Who Have Received a Prior BCMA-Targeting CAR T-Cell Therapy",
"has_exemption": false,
"start_date": "2026-10-30",
"completion_date": "2029-04-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07354100",
"publication_url": "https://clinicaltrials.gov/study/NCT07354100",
"title": "Bifidobacterium Lactulose Optimization in Oncology and Microbiome (BLOOM)",
"has_exemption": false,
"start_date": "2026-12-15",
"completion_date": "2029-04-13",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07582159",
"publication_url": "https://clinicaltrials.gov/study/NCT07582159",
"title": "A Phase 2 Study of Acalabrutinib, Venetoclax and Tafasitamab (AVT) in Patients With Previously Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)",
"has_exemption": false,
"start_date": "2026-12-19",
"completion_date": "2029-04-14",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07274527",
"publication_url": "https://clinicaltrials.gov/study/NCT07274527",
"title": "The PEARL Trial: A Randomized Trial of Amnioinfusion's Protective Effects on Respiratory and Longitudinal Pediatric Outcomes After Intrapartum Thick Meconium Exposure",
"has_exemption": false,
"start_date": "2026-05-15",
"completion_date": "2029-04-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06367361",
"publication_url": "https://clinicaltrials.gov/study/NCT06367361",
"title": "A Non-Inferiority, Randomized, Blind Laboratory Analysis, Controlled Trial Comparing One and Two Doses Regimes of Oxfendazole Versus a Two Dose Regime of Triclabendazole to Treat Chronic Fascioliasis",
"has_exemption": false,
"start_date": "2026-08-15",
"completion_date": "2029-04-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Universidad Peruana Cayetano Heredia",
"sponsor_slug": "universidad-peruana-cayetano-heredia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05739383",
"publication_url": "https://clinicaltrials.gov/study/NCT05739383",
"title": "A Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Effect of Inclisiran on Preventing Major Adverse Cardiovascular Events in High-risk Primary Prevention Patients (VICTORION-1 PREVENT)",
"has_exemption": false,
"start_date": "2023-03-09",
"completion_date": "2029-04-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07548164",
"publication_url": "https://clinicaltrials.gov/study/NCT07548164",
"title": "Alternative Boost Approaches in Radiation Therapy IRreversible Electroporation Versus RADIAtioN BoosT for Intermediate Risk Prostate Cancer (IRRADIANT)",
"has_exemption": false,
"start_date": "2026-04-16",
"completion_date": "2029-04-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06740526",
"publication_url": "https://clinicaltrials.gov/study/NCT06740526",
"title": "A Phase 2b, Multicenter, Open-label, Single-arm Trial to Evaluate the Impact of Sibeprenlimab on Kidney Histopathology Through Repeat Kidney Biopsies in Adolescents and Adults With Immunoglobulin A Nephropathy",
"has_exemption": false,
"start_date": "2024-11-19",
"completion_date": "2029-04-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Otsuka Pharmaceutical Development & Commercialization, Inc.",
"sponsor_slug": "otsuka-pharmaceutical-development-commercialization-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07092514",
"publication_url": "https://clinicaltrials.gov/study/NCT07092514",
"title": "Randomized Phase II Trial of Lenvatinib 24 mg/Day Versus 10 mg/Day to Treat Symptomatic or Progressive Radioactive Iodine Resistant (RAIR) Differentiated Thyroid Cancer (DTC)",
"has_exemption": false,
"start_date": "2025-10-14",
"completion_date": "2029-04-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07058012",
"publication_url": "https://clinicaltrials.gov/study/NCT07058012",
"title": "A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab and Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy",
"has_exemption": false,
"start_date": "2026-04-17",
"completion_date": "2029-04-17",
"has_results": false,
"results_due": false,
"sponsor_name": "NSABP Foundation Inc",
"sponsor_slug": "nsabp-foundation-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05952024",
"publication_url": "https://clinicaltrials.gov/study/NCT05952024",
"title": "A Prospective, Open-Label, Single-Arm, Phase II Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With Diffuse Large B-Cell Lymphoma (ACRUE)",
"has_exemption": false,
"start_date": "2024-07-16",
"completion_date": "2029-04-22",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06639074",
"publication_url": "https://clinicaltrials.gov/study/NCT06639074",
"title": "MC1963 Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for Patients With Advanced Stage Ovarian Cancer: A Phase II Double-Blind Randomized Clinical Trial (FAROUT)",
"has_exemption": false,
"start_date": "2024-11-12",
"completion_date": "2029-04-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07325136",
"publication_url": "https://clinicaltrials.gov/study/NCT07325136",
"title": "A Phase 1/2 Study of BMS-986525 as Monotherapy and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2026-02-03",
"completion_date": "2029-04-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04822181",
"publication_url": "https://clinicaltrials.gov/study/NCT04822181",
"title": "The Effect of Semaglutide in Subjects With Non-cirrhotic Non-alcoholic Steatohepatitis",
"has_exemption": false,
"start_date": "2021-04-01",
"completion_date": "2029-04-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Novo Nordisk A/S",
"sponsor_slug": "novo-nordisk-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05406401",
"publication_url": "https://clinicaltrials.gov/study/NCT05406401",
"title": "A Multicenter, Open-label, Phase 2 Dose Escalation and Confirmation, and Efficacy Expansion Study of Zilovertamab Vedotin (MK-2140) in Combination With R-CHP in Participants With DLBCL (waveLINE)",
"has_exemption": false,
"start_date": "2022-07-14",
"completion_date": "2029-04-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06764875",
"publication_url": "https://clinicaltrials.gov/study/NCT06764875",
"title": "A Randomized, Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan Versus Trastuzumab, Chemotherapy, and Pembrolizumab for the First Line Treatment of HER2-positive Gastric Cancer (ARTEMIDE-Gastric01)",
"has_exemption": false,
"start_date": "2025-03-01",
"completion_date": "2029-04-27",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06824467",
"publication_url": "https://clinicaltrials.gov/study/NCT06824467",
"title": "A Phase 3, Randomized, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan Maintenance Treatment With or Without Bevacizumab Versus Standard of Care After Second-line Platinum-based Doublet Chemotherapy in Participants With Platinum-sensitive Recurrent Ovarian Cancer (TroFuse-022/ENGOT-ov84/GOG-3103)",
"has_exemption": false,
"start_date": "2025-04-09",
"completion_date": "2029-04-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07284433",
"publication_url": "https://clinicaltrials.gov/study/NCT07284433",
"title": "A Single-arm, Multicenter, Open-label, Phase I/II Trial of Allo-QuadCAR01-T, an Allogeneic CAR-T-cell Therapy Targeting CD19 and CD20, for the Treatment of Relapsed or Refractory B-cell Malignancies",
"has_exemption": false,
"start_date": "2026-01-06",
"completion_date": "2029-04-27",
"has_results": false,
"results_due": false,
"sponsor_name": "AvenCell Therapeutics, Inc.",
"sponsor_slug": "avencell-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07366034",
"publication_url": "https://clinicaltrials.gov/study/NCT07366034",
"title": "A Study to Evaluate the Dose-exposure, Safety, and Exploratory Efficacy of Nerandomilast in Children and Adolescents From 2 Years to Less Than 18 Years of Age With Fibrosing Interstitial Lung Disease (Part A: Double-blind, Placebo-controlled in Children From 6 to Less Than 18 Years of Age and Open-label Active Treatment in Children From 2 to Less Than 6 Years of Age), Followed by an Open-label Phase With Active Treatment (Part B)",
"has_exemption": false,
"start_date": "2026-07-21",
"completion_date": "2029-04-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07485322",
"publication_url": "https://clinicaltrials.gov/study/NCT07485322",
"title": "Burn Pit Exposure in Veterans: A Cancer Screening Pilot Study at the Inova Saville Cancer Screening & Prevention Center",
"has_exemption": false,
"start_date": "2026-06-17",
"completion_date": "2029-04-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Inova Health Care Services",
"sponsor_slug": "inova-health-care-services",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07845812",
"publication_url": "https://clinicaltrials.gov/study/NCT07845812",
"title": "Short vs Standard Amoxicillin for Pediatric Strep Throat: A Patient-Centered Pragmatic Trial",
"has_exemption": false,
"start_date": "2026-09-28",
"completion_date": "2029-04-28",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07518186",
"publication_url": "https://clinicaltrials.gov/study/NCT07518186",
"title": "A Phase 3 Randomized Study Comparing JNJ-79635322 Versus Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma After 1 to 3 Prior Lines of Therapy, Including an Anti-CD38 Antibody and Lenalidomide",
"has_exemption": false,
"start_date": "2026-05-31",
"completion_date": "2029-04-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07850063",
"publication_url": "https://clinicaltrials.gov/study/NCT07850063",
"title": "A Multi-centre, Randomised, Double-blind, Placebo-controlled, Phase IIIb Trial to Evaluate the Effect of Survodutide on Cardiac Structure and Function of Participants With Overweight or Obesity and Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD); (ELEVATE-LIVER)",
"has_exemption": false,
"start_date": "2026-10-23",
"completion_date": "2029-04-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07874815",
"publication_url": "https://clinicaltrials.gov/study/NCT07874815",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine (MK-5884) Versus Placebo for the Prevention of COPD Exacerbations in Adults With a History of Moderate or Severe Exacerbations While Receiving Standard of Care (ENHANCE-3)",
"has_exemption": false,
"start_date": "2026-10-23",
"completion_date": "2029-04-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01590069",
"publication_url": "https://clinicaltrials.gov/study/NCT01590069",
"title": "Phase I/II Study of Aerosol Interleukin-2 for Pulmonary Metastases",
"has_exemption": false,
"start_date": "2012-06-28",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04156893",
"publication_url": "https://clinicaltrials.gov/study/NCT04156893",
"title": "RH Genotype Matched Red Cell Transfusions for Patients With Sickle Cell Disease",
"has_exemption": false,
"start_date": "2020-01-30",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Hospital of Philadelphia",
"sponsor_slug": "childrens-hospital-of-philadelphia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04499248",
"publication_url": "https://clinicaltrials.gov/study/NCT04499248",
"title": "A Phase 1/2 Study to Evaluate the Safety and Efficacy of AGN-193408 SR in Participants With Open-Angle Glaucoma or Ocular Hypertension",
"has_exemption": false,
"start_date": "2020-11-16",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04822337",
"publication_url": "https://clinicaltrials.gov/study/NCT04822337",
"title": "A Phase I/II Study of Carfilzomib, Lenalidomide, Dexamethasone and the Anti-B-Cell Maturation Antigen (BCMA) Antibody Drug Conjugate Belantamab Mafodotin in Multiple Myeloma",
"has_exemption": false,
"start_date": "2021-05-19",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Wake Forest University Health Sciences",
"sponsor_slug": "wake-forest-university-health-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05362760",
"publication_url": "https://clinicaltrials.gov/study/NCT05362760",
"title": "Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect Management. The MINERVA Trial - A Phase IV Trial",
"has_exemption": false,
"start_date": "2022-04-27",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Prof. Wolfgang Janni",
"sponsor_slug": "prof-wolfgang-janni",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05462106",
"publication_url": "https://clinicaltrials.gov/study/NCT05462106",
"title": "A Phase 1b/2, Multicenter, Adaptive, Double-blind, Randomized, Placebo-controlled Study to Assess the Safety, Tolerability, Immunogenicity, and Pharmacodynamic Effects of ACI-24.060 in Subjects With Prodromal Alzheimer's Disease and in Adults With Down Syndrome (ABATE)",
"has_exemption": false,
"start_date": "2022-06-21",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AC Immune SA",
"sponsor_slug": "ac-immune-sa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05484115",
"publication_url": "https://clinicaltrials.gov/study/NCT05484115",
"title": "Randomized Controlled Clinical Trial on the Application of Heli-FX EndoAnchors in Conjunction With the Endurant II/IIs Endograft in Infrarenal Aortic Aneurysms With a Wide Infrarenal Neck (HERCULES Trial)",
"has_exemption": false,
"start_date": "2023-05-26",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Rijnstate Hospital",
"sponsor_slug": "rijnstate-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05701241",
"publication_url": "https://clinicaltrials.gov/study/NCT05701241",
"title": "Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients - The SAUNA Trial",
"has_exemption": false,
"start_date": "2023-06-28",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University Hospital, Antwerp",
"sponsor_slug": "university-hospital-antwerp",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05995353",
"publication_url": "https://clinicaltrials.gov/study/NCT05995353",
"title": "A Phase 3, Multi-Center Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Risankizumab With Open-Label Induction, Randomized Double-Blind Maintenance, and Long-Term Extension Periods in Pediatric Subjects (2 to < 18 Years of Age) With Moderately to Severely Active Crohn's Disease",
"has_exemption": false,
"start_date": "2023-12-11",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05773274",
"publication_url": "https://clinicaltrials.gov/study/NCT05773274",
"title": "NET RETREAT: A Phase II Study of 177 Lutetium-DOTATATE Retreatment vs. Everolimus or Sunitinib or Cabozantinib in Metastatic/Unresectable Gastroenteropancreatic Neuroendocrine Tumours",
"has_exemption": false,
"start_date": "2024-01-12",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06372145",
"publication_url": "https://clinicaltrials.gov/study/NCT06372145",
"title": "An Interventional, Phase 3 Extension Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Relapsing Multiple Sclerosis, Primary Progressive Multiple Sclerosis, or Nonrelapsing Secondary Progressive Multiple Sclerosis",
"has_exemption": false,
"start_date": "2024-04-16",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06194799",
"publication_url": "https://clinicaltrials.gov/study/NCT06194799",
"title": "A 52-Week, Open-Label Extension Study of ACP-204 in Adults With Alzheimer's Disease Psychosis",
"has_exemption": false,
"start_date": "2024-04-23",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "ACADIA Pharmaceuticals Inc.",
"sponsor_slug": "acadia-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06029270",
"publication_url": "https://clinicaltrials.gov/study/NCT06029270",
"title": "A Randomized Phase II Study of Nivolumab Versus Nivolumab and BMS-986016 (Relatlimab) as Maintenance Treatment After First-Line Treatment With Platinum-Gemcitabine-Nivolumab for Patients With Epstein-Barr Virus-Associated Recurrent/Metastatic Nasopharyngeal Carcinoma (REMAIN)",
"has_exemption": false,
"start_date": "2024-07-15",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06512064",
"publication_url": "https://clinicaltrials.gov/study/NCT06512064",
"title": "Advancing Telemedicine in Pulmonology: Acoustic-waveform Respiratory Evaluation (AWARE) Via Sensing and Machine Learning on Smartphones",
"has_exemption": false,
"start_date": "2024-07-23",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Indiana University",
"sponsor_slug": "indiana-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05563766",
"publication_url": "https://clinicaltrials.gov/study/NCT05563766",
"title": "A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer",
"has_exemption": false,
"start_date": "2024-10-01",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06653153",
"publication_url": "https://clinicaltrials.gov/study/NCT06653153",
"title": "A Study of Remternetug Versus Placebo in Early Alzheimer's Disease Participants at Risk for Cognitive and Functional Decline",
"has_exemption": false,
"start_date": "2024-10-24",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06246799",
"publication_url": "https://clinicaltrials.gov/study/NCT06246799",
"title": "Comparative Effectiveness of Two Initial Combination Therapies in Patients With New Onset Diabetes",
"has_exemption": false,
"start_date": "2024-11-07",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center at San Antonio",
"sponsor_slug": "the-university-of-texas-health-science-center-at-san-antonio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06556563",
"publication_url": "https://clinicaltrials.gov/study/NCT06556563",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Optune® (TTFields, 200 kHz) Concomitant With Maintenance Temozolomide and Pembrolizumab Versus Optune® Concomitant With Maintenance Temozolomide and Placebo for the Treatment of Newly Diagnosed Glioblastoma (EF-41/KEYNOTE D58).",
"has_exemption": false,
"start_date": "2025-02-03",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "NovoCure GmbH",
"sponsor_slug": "novocure-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06712355",
"publication_url": "https://clinicaltrials.gov/study/NCT06712355",
"title": "A Phase III, Multisite, Double-blinded Randomized Trial of BNT327 in Combination With Chemotherapy (Etoposide/Carboplatin) Compared to Atezolizumab in Combination With Chemotherapy (Etoposide/Carboplatin) in Participants With First-line Extensive-stage Small-cell Lung Cancer",
"has_exemption": false,
"start_date": "2025-02-03",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Biontech SE",
"sponsor_slug": "biontech-se",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06932289",
"publication_url": "https://clinicaltrials.gov/study/NCT06932289",
"title": "Integrating Metabolic and Vascular Sensors to Monitor Cardiometabolic Disorders After Nutrition Interventions",
"has_exemption": false,
"start_date": "2025-05-01",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Greater Los Angeles Healthcare System",
"sponsor_slug": "va-greater-los-angeles-healthcare-system",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06754046",
"publication_url": "https://clinicaltrials.gov/study/NCT06754046",
"title": "BELIEVE Trial: Bulking vErsus sLing for Treating Stress Urinary IncontinEnce at the Time of Vaginal prolapsE Repair",
"has_exemption": false,
"start_date": "2025-05-01",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University Hospitals Cleveland Medical Center",
"sponsor_slug": "university-hospitals-cleveland-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06947083",
"publication_url": "https://clinicaltrials.gov/study/NCT06947083",
"title": "Phase II Study of Elranatamab as Maintenance Therapy Post Ciltacabtagene-autoleucel(Cilta-cel) in Patients With Clinical High Risk Relapsed Myeloma",
"has_exemption": false,
"start_date": "2025-05-27",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07033494",
"publication_url": "https://clinicaltrials.gov/study/NCT07033494",
"title": "A Phase 2 Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MK-2214 in Participants With Early Alzheimer's Disease",
"has_exemption": false,
"start_date": "2025-07-16",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06825390",
"publication_url": "https://clinicaltrials.gov/study/NCT06825390",
"title": "Mechanistic Clinical Trial of Auricular Stimulation and Cryogenic Auriculotherapy in Patients With Chronic Low-back Pain, Using Functional Near-infrared Spectroscopy and Magnetic Resonance Imaging",
"has_exemption": false,
"start_date": "2025-07-30",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Keith M Vogt",
"sponsor_slug": "keith-m-vogt",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07131475",
"publication_url": "https://clinicaltrials.gov/study/NCT07131475",
"title": "ReBlast Precision (Precision Biomarkers to Detect Brain Injury in Active-Duty United States Special Operations Forces With Repeated Blast Exposure)",
"has_exemption": false,
"start_date": "2025-10-14",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07177339",
"publication_url": "https://clinicaltrials.gov/study/NCT07177339",
"title": "A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Study of the Efficacy and Safety of Early Depemokimab Initiation as add-on Treatment in COPD Patients With Type 2 Inflammation",
"has_exemption": false,
"start_date": "2025-10-20",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07210255",
"publication_url": "https://clinicaltrials.gov/study/NCT07210255",
"title": "A Randomized Controlled Multi-site Trial Evaluating SAINT for Postpartum Depression",
"has_exemption": false,
"start_date": "2025-11-01",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Magnus Medical",
"sponsor_slug": "magnus-medical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07155174",
"publication_url": "https://clinicaltrials.gov/study/NCT07155174",
"title": "A Phase 2 Randomized, Open Label, Multicenter Study to Evaluate the Optimal Dose, Safety, and Efficacy of ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Subjects With Previously Untreated Extensive Stage Small Cell Lung Cancer (ES-SCLC)",
"has_exemption": false,
"start_date": "2025-11-25",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07298993",
"publication_url": "https://clinicaltrials.gov/study/NCT07298993",
"title": "Determining Evidence in a Placebo-Controlled, Randomized Experiment Studying Continuation vs. Removal of Inessential Beta-Blockers in Elders With Heart Failure With Preserved Ejection Fraction (DEPRESCRIBE-HFpEF)",
"has_exemption": false,
"start_date": "2026-02-02",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Weill Medical College of Cornell University",
"sponsor_slug": "weill-medical-college-of-cornell-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03176186",
"publication_url": "https://clinicaltrials.gov/study/NCT03176186",
"title": "XePOHCAS - Xenon by Inhalation for Post Out of Hospital Cardiac Arrest Syndrome",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Invero Pharma, Inc.",
"sponsor_slug": "invero-pharma-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07516925",
"publication_url": "https://clinicaltrials.gov/study/NCT07516925",
"title": "Vonescimab for the Treatment of Previously Treated Advanced or Unresectable Leiomyosarcoma - a Phase II Trial",
"has_exemption": false,
"start_date": "2026-04-01",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07582523",
"publication_url": "https://clinicaltrials.gov/study/NCT07582523",
"title": "Out-of-office Monitoring for Rhythms Of Normal Versus Atrial Fibrillation",
"has_exemption": false,
"start_date": "2026-04-01",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07423078",
"publication_url": "https://clinicaltrials.gov/study/NCT07423078",
"title": "A Phase II Window of Opportunity in Preserving Laryngeal Function (WOLF) Trial",
"has_exemption": false,
"start_date": "2026-04-06",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Matthew Spector",
"sponsor_slug": "matthew-spector",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07344168",
"publication_url": "https://clinicaltrials.gov/study/NCT07344168",
"title": "A Prospective, Open-label, Single Arm Study to Evaluate the Safety and Effectiveness of the EndoArt® in Subjects With Chronic Corneal Edema in Whom Multiple Prior Keratoplasty (EK/PK) Have Failed, and Who Are Not Reasonable Candidates for Any Form of Corneal Transplant, Including Penetrating Keratoplasty",
"has_exemption": false,
"start_date": "2026-05-01",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eye-yon Medical",
"sponsor_slug": "eye-yon-medical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07512284",
"publication_url": "https://clinicaltrials.gov/study/NCT07512284",
"title": "Mindfulness Engaged Neurostimulation for Depression",
"has_exemption": false,
"start_date": "2026-05-01",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Diego",
"sponsor_slug": "university-of-california-san-diego",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07422480",
"publication_url": "https://clinicaltrials.gov/study/NCT07422480",
"title": "A Phase 3, Multicenter, Open-Label, Randomized Trial to Compare the Efficacy and Safety of Elritercept Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes in ESA-naïve Adult Participants Who Require Red Blood Cell Transfusions",
"has_exemption": false,
"start_date": "2026-05-21",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07492641",
"publication_url": "https://clinicaltrials.gov/study/NCT07492641",
"title": "An Open-Label, Randomized, Multicenter Phase 3 Study Investigating the Efficacy and Safety of BGB-43395 Plus Letrozole Versus CDK4/6 Inhibitors (Abemaciclib, Palbociclib, Ribociclib) Plus Letrozole in Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Systemic Anticancer Treatment for Advanced or Metastatic Disease",
"has_exemption": false,
"start_date": "2026-05-22",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "BeOne Medicines",
"sponsor_slug": "beone-medicines",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07043608",
"publication_url": "https://clinicaltrials.gov/study/NCT07043608",
"title": "A Phase II Study of Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases in Patients Previously Treated With Immune Checkpoint Inhibitors",
"has_exemption": false,
"start_date": "2026-06-10",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Kelly Fitzgerald, MD",
"sponsor_slug": "kelly-fitzgerald-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07592858",
"publication_url": "https://clinicaltrials.gov/study/NCT07592858",
"title": "Use of Bile Acid Binding Resins to Decrease Systemic Per- and Polyfluoroalkyl Substance (PFAS) Levels and Improve Serum Lipid Profiles in Veterans: PFAS Reduction in Veterans Via Colesevalem Study (PAVERS) Study",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Rhode Island",
"sponsor_slug": "university-of-rhode-island",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07554638",
"publication_url": "https://clinicaltrials.gov/study/NCT07554638",
"title": "Identifying Therapeutic Mechanisms for Incretin-Based Treatment in Obesity-Related Heart Failure With Preserved Ejection Fraction (HFpEF)",
"has_exemption": false,
"start_date": "2026-08-07",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Columbia University",
"sponsor_slug": "columbia-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07712562",
"publication_url": "https://clinicaltrials.gov/study/NCT07712562",
"title": "A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Dibotatug in Adults With Bone Marrow Failure Syndromes",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Dren Bio",
"sponsor_slug": "dren-bio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07029945",
"publication_url": "https://clinicaltrials.gov/study/NCT07029945",
"title": "A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration",
"has_exemption": false,
"start_date": "2026-09-29",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Biojiva LLC",
"sponsor_slug": "biojiva-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07686081",
"publication_url": "https://clinicaltrials.gov/study/NCT07686081",
"title": "A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ponesimod in Patients With Moderately to Severely Active Ulcerative Colitis",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vanda Pharmaceuticals",
"sponsor_slug": "vanda-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07799246",
"publication_url": "https://clinicaltrials.gov/study/NCT07799246",
"title": "BLOOM Study: Investigation of Endometriosis Treatments on Brain and Cerebrovascular Health",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Colorado State University",
"sponsor_slug": "colorado-state-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07824960",
"publication_url": "https://clinicaltrials.gov/study/NCT07824960",
"title": "Neoadjuvant Avutometinib/Defactinib and mFOLFIRINOX Combination Therapy in Pancreatic Adenocarcinoma: A Phase IB/II Safety and Efficacy Study",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Virginia",
"sponsor_slug": "university-of-virginia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07710196",
"publication_url": "https://clinicaltrials.gov/study/NCT07710196",
"title": "A 24-Month, Randomized, Double-Masked, Placebo-Controlled Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis PigmentosaAssociated With Usher Syndrome",
"has_exemption": false,
"start_date": "2026-10-31",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Nacuity Pharmaceuticals, Inc.",
"sponsor_slug": "nacuity-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07756736",
"publication_url": "https://clinicaltrials.gov/study/NCT07756736",
"title": "Psilocybin Recovery Intervention for Stopping Methamphetamine Use",
"has_exemption": false,
"start_date": "2026-11-30",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Nicky Mehtani, MD, MPH",
"sponsor_slug": "nicky-mehtani-md-mph",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07840001",
"publication_url": "https://clinicaltrials.gov/study/NCT07840001",
"title": "Neoadjuvant Belzutifan Plus Pembrolizumab in High-Risk, Locally Advanced Clear Cell Renal Cell Carcinoma",
"has_exemption": false,
"start_date": "2026-12-31",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Peter MacCallum Cancer Centre, Australia",
"sponsor_slug": "peter-maccallum-cancer-centre-australia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07153055",
"publication_url": "https://clinicaltrials.gov/study/NCT07153055",
"title": "Phase I/II Trial of Lurbinectedin With Osimertinib in Transformed Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2027-01-31",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Misty Shields",
"sponsor_slug": "misty-shields",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07743489",
"publication_url": "https://clinicaltrials.gov/study/NCT07743489",
"title": "Light for Ulcer Management by Infection Elimination and Resistance Enhancement (LUMIERE)",
"has_exemption": false,
"start_date": "2027-01-31",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07803679",
"publication_url": "https://clinicaltrials.gov/study/NCT07803679",
"title": "A Phase 4, Open-label, Blinded Primary Endpoint, Randomized Multicenter Trial to Assess the Effectiveness of Evolocumab With Routine Lipid Management Compared With Routine Lipid Management Alone in Reducing the Plaque Burden in Patients With Subclinical Atheroma",
"has_exemption": false,
"start_date": "2027-01-31",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07843134",
"publication_url": "https://clinicaltrials.gov/study/NCT07843134",
"title": "Non-Opioid Postoperative Pain Management in Skin Cancer Surgery: A Randomized Trial of Suzetrigine Versus Standard Analgesia in Minnesota",
"has_exemption": false,
"start_date": "2027-04-01",
"completion_date": "2029-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05556902",
"publication_url": "https://clinicaltrials.gov/study/NCT05556902",
"title": "Therapeutic Mechanisms of Epidural Spinal Cord Stimulation",
"has_exemption": false,
"start_date": "2022-08-02",
"completion_date": "2029-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06345963",
"publication_url": "https://clinicaltrials.gov/study/NCT06345963",
"title": "Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)",
"has_exemption": false,
"start_date": "2024-05-21",
"completion_date": "2029-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06327100",
"publication_url": "https://clinicaltrials.gov/study/NCT06327100",
"title": "Open Label Phase 1/2 Study of Tasquinimod in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), or Post-Essential Thrombocytosis Myelofibrosis (Post-ET MF)",
"has_exemption": false,
"start_date": "2024-08-01",
"completion_date": "2029-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06494111",
"publication_url": "https://clinicaltrials.gov/study/NCT06494111",
"title": "Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE)",
"has_exemption": false,
"start_date": "2025-02-13",
"completion_date": "2029-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06897930",
"publication_url": "https://clinicaltrials.gov/study/NCT06897930",
"title": "A Phase 1b/2 Study of AZD0120, a Chimeric Antigen Receptor T-cell (CAR T) Therapy Targeting CD19 and B-cell Maturation Antigen (BCMA) in Subjects With Refractory Systemic Lupus Erythematosus (SLE)",
"has_exemption": false,
"start_date": "2025-04-21",
"completion_date": "2029-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06909110",
"publication_url": "https://clinicaltrials.gov/study/NCT06909110",
"title": "Viral Specific T-Lymphocytes by Cytokine Capture System (CCS) to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus After Hematopoietic Cell Transplantation or Solid Organ Transplantation and in Patients With Compromised Immunity",
"has_exemption": false,
"start_date": "2025-04-30",
"completion_date": "2029-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jessie L. Alexander",
"sponsor_slug": "jessie-l-alexander",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06261840",
"publication_url": "https://clinicaltrials.gov/study/NCT06261840",
"title": "Refining Treatment Options for Trichomonas Vaginalis Infection in Women and Men: A Comparative Analysis of Oral Multi-Dose Metronidazole and Single-Dose Secnidazole",
"has_exemption": false,
"start_date": "2025-05-06",
"completion_date": "2029-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Tulane University",
"sponsor_slug": "tulane-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06961916",
"publication_url": "https://clinicaltrials.gov/study/NCT06961916",
"title": "Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 2)",
"has_exemption": false,
"start_date": "2025-06-03",
"completion_date": "2029-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06999577",
"publication_url": "https://clinicaltrials.gov/study/NCT06999577",
"title": "The MVP Trial: A Randomized Controlled Trial of Mechanism Guided vs PPI Strategy for Laryngopharyngeal Reflux",
"has_exemption": false,
"start_date": "2025-06-04",
"completion_date": "2029-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Diego",
"sponsor_slug": "university-of-california-san-diego",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06501820",
"publication_url": "https://clinicaltrials.gov/study/NCT06501820",
"title": "Neural Control of Gait & Navigation in ADRD, Aim 3 Clinical Trial",
"has_exemption": false,
"start_date": "2025-11-13",
"completion_date": "2029-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05950659",
"publication_url": "https://clinicaltrials.gov/study/NCT05950659",
"title": "Prevention of Foot Ulcer Recurrence in Individuals Who Are at High-risk for Diabetic Foot Complications Using the Orpyx Sensory Insole System: a Multisite, Randomized, Controlled Trial",
"has_exemption": false,
"start_date": "2026-04-22",
"completion_date": "2029-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07530796",
"publication_url": "https://clinicaltrials.gov/study/NCT07530796",
"title": "An Open-Label, Single Center, Phase 1/2 Study to Evaluate the Safety and Efficacy of DANAGALEX (scAAV9/AGA) in Participants With Aspartylglucosaminuria (AGU)",
"has_exemption": false,
"start_date": "2026-05-01",
"completion_date": "2029-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Rare Trait Hope",
"sponsor_slug": "rare-trait-hope",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07553975",
"publication_url": "https://clinicaltrials.gov/study/NCT07553975",
"title": "Randomized Study Evaluating Cost of Arthrex Nano Arthroscopy Products in Arthroscopic Knee ACL Surgery Versus Conventional Arthroscopy",
"has_exemption": false,
"start_date": "2026-05-01",
"completion_date": "2029-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07413939",
"publication_url": "https://clinicaltrials.gov/study/NCT07413939",
"title": "A Two-part, Seamless, Multicenter, Randomized, Open-label, Adaptive Phase II/III Study of the Blood-brain Barrier Penetrant RO7771950 Versus Tucatinib, Both in Combination With Trastuzumab and Capecitabine, in Patients With Pretreated Unresectable Locally Advanced or Metastatic HER2-Positive Breast Cancer, With or Without Central Nervous System Metastases",
"has_exemption": false,
"start_date": "2026-05-21",
"completion_date": "2029-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07024706",
"publication_url": "https://clinicaltrials.gov/study/NCT07024706",
"title": "The MAVRiC Study: A Phase II Study of Disease Risk Mutation Guided Finite Duration Acalabrutinib Plus Venetoclax for Relapse in CLL/SLL After First-line Finite Covalent BTKi Plus BCL2i Combination, With or Without Obinutuzumab",
"has_exemption": false,
"start_date": "2026-06-04",
"completion_date": "2029-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07772349",
"publication_url": "https://clinicaltrials.gov/study/NCT07772349",
"title": "Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 3)",
"has_exemption": false,
"start_date": "2026-10-01",
"completion_date": "2029-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07846215",
"publication_url": "https://clinicaltrials.gov/study/NCT07846215",
"title": "A Phase II, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Safety, Efficacy, and Pharmacodynamics of Basmisanil in Participants Aged 2 to 14 Years Old With Dup15q Syndrome",
"has_exemption": false,
"start_date": "2026-12-01",
"completion_date": "2029-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Newleos Therapeutics, Inc.",
"sponsor_slug": "newleos-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07712380",
"publication_url": "https://clinicaltrials.gov/study/NCT07712380",
"title": "A Randomized, Observer-blind, Placebo-controlled Exploratory Study to Evaluate Whether Administration of Adjuvanted RZV or RSVPreF3 Vaccine Can Attenuate Coronary Plaque Progression in Individuals 50 Years of Age and Above Who Are at Risk for Cardiovascular Events",
"has_exemption": false,
"start_date": "2026-10-23",
"completion_date": "2029-05-02",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06137144",
"publication_url": "https://clinicaltrials.gov/study/NCT06137144",
"title": "A Modular Phase I/II, Open-label, Multicentre Study to Evaluate the Safety, Tolerability, and Efficacy of AZD3470, a PRMT5 Inhibitor, as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies",
"has_exemption": false,
"start_date": "2024-01-23",
"completion_date": "2029-05-03",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07197866",
"publication_url": "https://clinicaltrials.gov/study/NCT07197866",
"title": "An Open-Label Extension, Multi-Centered, Phase 2 Trial to Describe the Safety and Efficacy of TEV-56286 (Emrusolmin) in Participants With Multiple System Atrophy",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2029-05-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Teva Branded Pharmaceutical Products R&D LLC",
"sponsor_slug": "teva-branded-pharmaceutical-products-rd-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07076121",
"publication_url": "https://clinicaltrials.gov/study/NCT07076121",
"title": "A Randomized, Phase 2/3 Study Comparing Navlimetostat (BMS-986504) in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma Harboring Homozygous MTAP Deletion",
"has_exemption": false,
"start_date": "2025-10-23",
"completion_date": "2029-05-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07782996",
"publication_url": "https://clinicaltrials.gov/study/NCT07782996",
"title": "A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of GSK5784283 (Felcorekibart) as an Add-On Therapy in Adults and Adolescents With Uncontrolled Asthma (PERSIST ASTHMA-2)",
"has_exemption": false,
"start_date": "2026-08-27",
"completion_date": "2029-05-04",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07493577",
"publication_url": "https://clinicaltrials.gov/study/NCT07493577",
"title": "Induced Suppression of Platelet Activity in Aneurysmal Subarachnoid Hemorrhage Management-2",
"has_exemption": false,
"start_date": "2026-11-05",
"completion_date": "2029-05-05",
"has_results": false,
"results_due": false,
"sponsor_name": "Dr David Hasan, M.D.",
"sponsor_slug": "dr-david-hasan-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07048262",
"publication_url": "https://clinicaltrials.gov/study/NCT07048262",
"title": "A Phase 2b, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Dose Range Finding Study to Evaluate the Efficacy, Safety, and Tolerability of Nebulized CSL787 in Adults (18 to 85 Years) With Non-cystic Fibrosis Bronchiectasis",
"has_exemption": false,
"start_date": "2025-09-03",
"completion_date": "2029-05-06",
"has_results": false,
"results_due": false,
"sponsor_name": "CSL Behring",
"sponsor_slug": "csl-behring",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06976476",
"publication_url": "https://clinicaltrials.gov/study/NCT06976476",
"title": "Prospective Randomized Phase II Study Evaluating Efficacy and Safety of IgPro20 as Infection Prophylaxis in Patients With Multiple Myeloma and Hypogammaglobulinemia Receiving Therapy With a Bispecific Monoclonal Antibody (BsAbs)",
"has_exemption": false,
"start_date": "2025-05-08",
"completion_date": "2029-05-08",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06630416",
"publication_url": "https://clinicaltrials.gov/study/NCT06630416",
"title": "A Phase II Trial to Evaluate Pemetrexed Response in Relation to Tumor Alterations of Gene Status in Patients With Previously Treated Metastatic Urothelial Carcinoma and Other Solid Tumors",
"has_exemption": false,
"start_date": "2024-11-27",
"completion_date": "2029-05-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07252232",
"publication_url": "https://clinicaltrials.gov/study/NCT07252232",
"title": "RASolute 304: A Phase 3 Multicenter, Open-label, Randomized, 2-Arm Study of Adjuvant Daraxonrasib Versus Standard of Care Observation Following Completion of Neoadjuvant and/or Adjuvant Chemotherapy in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)",
"has_exemption": false,
"start_date": "2025-12-15",
"completion_date": "2029-05-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Revolution Medicines, Inc.",
"sponsor_slug": "revolution-medicines-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05555732",
"publication_url": "https://clinicaltrials.gov/study/NCT05555732",
"title": "A Randomized Phase 3 Study of Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in Subjects With No Prior Therapy for Advanced or Metastatic PD-L1 TPS <50% Non-squamous Non-small Cell Lung Cancer Without Actionable Genomic Alterations (TROPION-Lung07)",
"has_exemption": false,
"start_date": "2023-01-11",
"completion_date": "2029-05-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07184931",
"publication_url": "https://clinicaltrials.gov/study/NCT07184931",
"title": "A Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled Phase 3, Induction Study to Evaluate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2029-05-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07201922",
"publication_url": "https://clinicaltrials.gov/study/NCT07201922",
"title": "A Double Blind, Randomized, Placebo-controlled Exploratory Trial to Investigate the Efficacy and Safety of Nerandomilast Over 24 Months When Administered in Individuals With Interstitial Lung Abnormalities and a Family History of Pulmonary Fibrosis to Reduce the Risk of Worsening (DROP-FPF)",
"has_exemption": false,
"start_date": "2026-02-10",
"completion_date": "2029-05-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Boehringer Ingelheim",
"sponsor_slug": "boehringer-ingelheim",
"status": "ongoing",
"is_pact": false,
"days_late": null
}
]
}